GB2609039A - Cellulosic microporous superabsorbent materials with tunable morphology - Google Patents
Cellulosic microporous superabsorbent materials with tunable morphology Download PDFInfo
- Publication number
- GB2609039A GB2609039A GB2110423.7A GB202110423A GB2609039A GB 2609039 A GB2609039 A GB 2609039A GB 202110423 A GB202110423 A GB 202110423A GB 2609039 A GB2609039 A GB 2609039A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antimicrobial
- cellulose
- peptides
- proteins
- microparticles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000463 material Substances 0.000 title claims abstract description 171
- 239000001913 cellulose Substances 0.000 claims abstract description 172
- 229920002678 cellulose Polymers 0.000 claims abstract description 172
- 239000000203 mixture Substances 0.000 claims abstract description 145
- 230000000845 anti-microbial effect Effects 0.000 claims abstract description 83
- 239000002245 particle Substances 0.000 claims abstract description 79
- 238000000034 method Methods 0.000 claims abstract description 69
- 239000011859 microparticle Substances 0.000 claims abstract description 53
- 239000004599 antimicrobial Substances 0.000 claims abstract description 47
- 239000002243 precursor Substances 0.000 claims abstract description 42
- 230000008569 process Effects 0.000 claims abstract description 36
- 239000007864 aqueous solution Substances 0.000 claims abstract description 24
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 20
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 15
- 239000000758 substrate Substances 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 11
- 230000001433 inducive effect Effects 0.000 claims abstract description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims description 97
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 61
- 102000004169 proteins and genes Human genes 0.000 claims description 60
- 108090000623 proteins and genes Proteins 0.000 claims description 60
- 229910052709 silver Inorganic materials 0.000 claims description 51
- 239000004332 silver Substances 0.000 claims description 51
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 49
- 239000011236 particulate material Substances 0.000 claims description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 38
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 32
- 238000005406 washing Methods 0.000 claims description 27
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 24
- 102400000830 Saposin-B Human genes 0.000 claims description 23
- 101800001697 Saposin-B Proteins 0.000 claims description 23
- 238000001035 drying Methods 0.000 claims description 23
- 229910052737 gold Inorganic materials 0.000 claims description 21
- 239000010931 gold Substances 0.000 claims description 21
- 102000044503 Antimicrobial Peptides Human genes 0.000 claims description 20
- 108700042778 Antimicrobial Peptides Proteins 0.000 claims description 20
- 239000002250 absorbent Substances 0.000 claims description 19
- 230000002745 absorbent Effects 0.000 claims description 19
- 229910052751 metal Inorganic materials 0.000 claims description 19
- 239000002184 metal Substances 0.000 claims description 19
- 230000000844 anti-bacterial effect Effects 0.000 claims description 17
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 17
- 229910001961 silver nitrate Inorganic materials 0.000 claims description 17
- 238000002386 leaching Methods 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 15
- 230000000840 anti-viral effect Effects 0.000 claims description 14
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 13
- 229910052802 copper Inorganic materials 0.000 claims description 13
- 239000010949 copper Substances 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 239000003463 adsorbent Substances 0.000 claims description 12
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 150000001875 compounds Chemical class 0.000 claims description 10
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 10
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 claims description 10
- 238000012986 modification Methods 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 10
- 229920000742 Cotton Polymers 0.000 claims description 9
- 241000700605 Viruses Species 0.000 claims description 9
- 239000000123 paper Substances 0.000 claims description 9
- 150000003378 silver Chemical class 0.000 claims description 9
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 229910000366 copper(II) sulfate Inorganic materials 0.000 claims description 7
- 238000002955 isolation Methods 0.000 claims description 7
- 238000012856 packing Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 108010086593 lactoferrampin Proteins 0.000 claims description 6
- -1 lumber Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 150000001879 copper Chemical class 0.000 claims description 5
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 claims description 5
- 150000002343 gold Chemical class 0.000 claims description 5
- 230000000813 microbial effect Effects 0.000 claims description 5
- 238000003860 storage Methods 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 4
- 230000006378 damage Effects 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 239000000383 hazardous chemical Substances 0.000 claims description 4
- 239000002082 metal nanoparticle Substances 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 210000000416 exudates and transudate Anatomy 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- QYTDEUPAUMOIOP-UHFFFAOYSA-N TEMPO Chemical group CC1(C)CCCC(C)(C)N1[O] QYTDEUPAUMOIOP-UHFFFAOYSA-N 0.000 claims description 2
- 229940088710 antibiotic agent Drugs 0.000 claims description 2
- 239000007795 chemical reaction product Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 244000000010 microbial pathogen Species 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 claims description 2
- 239000012670 alkaline solution Substances 0.000 claims 4
- 235000013372 meat Nutrition 0.000 claims 3
- 229910044991 metal oxide Inorganic materials 0.000 claims 3
- 150000004706 metal oxides Chemical class 0.000 claims 3
- 239000005022 packaging material Substances 0.000 claims 3
- 229910052783 alkali metal Inorganic materials 0.000 claims 2
- 150000001340 alkali metals Chemical class 0.000 claims 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 102000014961 Protein Precursors Human genes 0.000 claims 1
- 108010078762 Protein Precursors Proteins 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 230000000843 anti-fungal effect Effects 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 claims 1
- 230000002141 anti-parasite Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000003096 antiparasitic agent Substances 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000008366 buffered solution Substances 0.000 claims 1
- 150000003841 chloride salts Chemical class 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 230000000855 fungicidal effect Effects 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 claims 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 claims 1
- 210000004914 menses Anatomy 0.000 claims 1
- 239000007800 oxidant agent Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 206010052428 Wound Diseases 0.000 abstract description 26
- 208000027418 Wounds and injury Diseases 0.000 abstract description 26
- 239000002105 nanoparticle Substances 0.000 description 104
- 241000196324 Embryophyta Species 0.000 description 49
- 230000001580 bacterial effect Effects 0.000 description 23
- 239000007787 solid Substances 0.000 description 22
- 229910017745 AgNP Inorganic materials 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 20
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 19
- 230000012010 growth Effects 0.000 description 19
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 17
- 239000002953 phosphate buffered saline Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 15
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 14
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 14
- 239000005090 green fluorescent protein Substances 0.000 description 14
- 239000011149 active material Substances 0.000 description 13
- 238000001914 filtration Methods 0.000 description 13
- 239000002002 slurry Substances 0.000 description 13
- 239000007858 starting material Substances 0.000 description 13
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 11
- 235000021536 Sugar beet Nutrition 0.000 description 11
- 230000000694 effects Effects 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 230000000717 retained effect Effects 0.000 description 9
- 125000003345 AMP group Chemical group 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 229920006227 ethylene-grafted-maleic anhydride Polymers 0.000 description 8
- 229920005610 lignin Polymers 0.000 description 8
- 244000005700 microbiome Species 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 238000011065 in-situ storage Methods 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 210000000981 epithelium Anatomy 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000010408 film Substances 0.000 description 6
- 230000035876 healing Effects 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 6
- 238000003359 percent control normalization Methods 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 239000011343 solid material Substances 0.000 description 6
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000001095 inductively coupled plasma mass spectrometry Methods 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 241000335053 Beta vulgaris Species 0.000 description 4
- XNCOSPRUTUOJCJ-UHFFFAOYSA-N Biguanide Chemical compound NC(N)=NC(N)=N XNCOSPRUTUOJCJ-UHFFFAOYSA-N 0.000 description 4
- 229940123208 Biguanide Drugs 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 229910003771 Gold(I) chloride Inorganic materials 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000010261 cell growth Effects 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 150000001805 chlorine compounds Chemical class 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- FDWREHZXQUYJFJ-UHFFFAOYSA-M gold monochloride Chemical compound [Cl-].[Au+] FDWREHZXQUYJFJ-UHFFFAOYSA-M 0.000 description 4
- 208000037797 influenza A Diseases 0.000 description 4
- 239000001573 invertase Substances 0.000 description 4
- 235000011073 invertase Nutrition 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 230000003253 viricidal effect Effects 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 3
- 235000016068 Berberis vulgaris Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000010924 continuous production Methods 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000003801 milling Methods 0.000 description 3
- JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 240000002791 Brassica napus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 206010011985 Decubitus ulcer Diseases 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000309467 Human Coronavirus Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920001046 Nanocellulose Polymers 0.000 description 2
- 229920002201 Oxidized cellulose Polymers 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- 241000702217 Pseudomonas virus phi6 Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000592342 Tracheophyta Species 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 238000002679 ablation Methods 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000007975 buffered saline Substances 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 230000008045 co-localization Effects 0.000 description 2
- 238000007398 colorimetric assay Methods 0.000 description 2
- 239000002361 compost Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 229940107304 oxidized cellulose Drugs 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000013643 reference control Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000013501 sustainable material Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000005727 virus proliferation Effects 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- 235000021533 Beta vulgaris Nutrition 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 229910003803 Gold(III) chloride Inorganic materials 0.000 description 1
- 241000482741 Human coronavirus NL63 Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 208000005230 Leg Ulcer Diseases 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241001516739 Platonia insignis Species 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000589615 Pseudomonas syringae Species 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- FXXACINHVKSMDR-UHFFFAOYSA-N acetyl bromide Chemical compound CC(Br)=O FXXACINHVKSMDR-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003214 anti-biofilm Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- QZPSXPBJTPJTSZ-UHFFFAOYSA-N aqua regia Chemical compound Cl.O[N+]([O-])=O QZPSXPBJTPJTSZ-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002296 dynamic light scattering Methods 0.000 description 1
- 230000000531 effect on virus Effects 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- RJHLTVSLYWWTEF-UHFFFAOYSA-K gold trichloride Chemical compound Cl[Au](Cl)Cl RJHLTVSLYWWTEF-UHFFFAOYSA-K 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000012943 hotmelt Substances 0.000 description 1
- 125000001165 hydrophobic group Chemical group 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000001465 metallisation Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000003616 phosphatase activity assay Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000011369 resultant mixture Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- 238000005549 size reduction Methods 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229940096399 yucca root Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
- A01N25/10—Macromolecular compounds
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
- A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/16—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
- A01N65/08—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D46/00—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours
- B01D46/0027—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours with additional separating or treating functions
- B01D46/0028—Filters or filtering processes specially modified for separating dispersed particles from gases or vapours with additional separating or treating functions provided with antibacterial or antifungal means
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
A process for preparing an antimicrobial cellulose-containing microporous superabsorbent composition from an herbaceous plant material, the process comprising the step of comminuting dry granulated herbaceous plant material to form microparticles having an average particle diameter of from 100μm to 800μm. Optionally the microparticles may then be contacted with an aqueous solution (preferably comprising an alkaline reagent) to wash out soluble components, the aqueous solution then removed from the washed microparticles; and also optionally, the microparticles dried. Optionally, a film may be formed and allowed to dry. Finally, the process comprises at least once contacting the microparticles or the microparticle film with an antimicrobial agent precursor under conditions inducive of the formation, attachment or binding of an antimicrobial agent; followed by isolating the antimicrobially modified microporous superabsorbent composition or the antimicrobially modified microporous film. In one embodiment, an antimicrobial composition obtained by the described process comprises an herbaceous cellulose-containing substrate and an antimicrobial agent adhered to the substrate. A substrate comprising the composition may be used in methods of treating or covering wounds.
Description
CELLULOSIC MICROPOROUS SUPERABSORBENT MATERIALS WITH TUNABLE MORPHOLOGY
Technical Field
The present invention relates to a process for preparing cellulose-containing adsorbent materials with tuneable morphology and antimicrobial activity from herbaceous plant material. The materials are useful for a wide variety of applications, such as air filtration; water filtration; garments; surgical bandages and packing materials, and generally, any application where the ability adsorb and desorb humidity and stop bacterial growth and/or viral proliferation is desired. The invention also relates to methods and compositions for materials having a non-leaching component that imparts antimicrobial properties. The modification may be applied to cellulose-containing adsorbent materials such as particulate cellulose-containing adsorbents, or films prepared therefrom, resulting in essentially non-leaching modification of substrates, which impart to the absorbent a high antimicrobial efficacy.
Background to the Invention
The present invention relates generally to the field of cellulosic adsorbent materials, more specifically to highly adsorbent materials with added antimicrobial activity, and their use in a variety of different applications, including materials for air filtration; water filtration; garments; surgical bandages and packing materials, and generally, any application where the ability to adsorb and desorb humidity and stop bacterial growth and/or viral proliferation is desired. It is known in the art that antimicrobial agents can enhance the antimicrobial activity of a material. These include metal modification, in particular by copper or silver deposition, which may exhibit strong antimicrobial properties. Also known are antimicrobial peptides, e.g. proteolytic enzymes that can attack and destroy bacteria, fungi or virus. However, the modification of absorbent materials has not been very successful, and usually results in leaching, or loss of activity upon washing and/or drying. The known prior art processes for formation of metal nanoparticles are usually complex, often requiring high temperature treatment and as such there is a need for much simpler methods.
A major function of adsorbents is the absorption of various fluids. These fluids, e.g. wound exudates, are frequently rich in nutrients and are capable of supporting abundant bacterial growth. Since the surgical opening or skin surface is rarely absolutely free of bacteria, the bandage material soon supports a burgeoning bacterial population. These bacteria can easily cause serious infection and may also release a variety of harmful toxins. Filter materials may also acquire a number of biological pathogens, such as microbes and viral particles by physical adsorption to the surface thereto, but once the surface is saturated, these may be released and leach out into the medium. This is in particular relevant for filters that are to be reused, e.g. filter materials for breathing air, e.g. face masks or HVAC filters for vehicles or buildings, wherein the filters traditionally have been replaced once fully loaded.
Unfortunately, it had proven difficult to produce an effective disinfectant that does not readily wash out of the material, in particular when subjected to an industrial our household detergents and washing and drying process. Hence wash out, or leaching usually occurs, which reduces effectiveness and may cause irritation, or infections. This is a general problem where absorptive packings are placed in contact with significant possibility for dangerous pathogen load, e.g. bacterial growth. When used for care products, particularly tampons, the well-known "toxic shock syndrome" results from multiplication of Staphylococcus aureus bacteria.
In addition, due to the globalization of transport, the emergence of new diseases and pandemics, the uses for a technology that imparts an essentially non-leaching re-useable antimicrobial modification to a variety of materials is duly recognized. Specific areas of use are described below herein. And last but not least, sustainable materials would be desired which may simply be subjected to compost preparations, preferably after extraction of valuable antimicrobial components, metals and the like.
In conclusion, with regard to the above descriptions of the art, it is apparent that there is a need for an improved adsorbent that has enhanced antimicrobial abilities, is superabsorbent, and can be modified easily, and is non-leaching upon use, washable and reusable, and that allows recycling at the end of life due to entirely sustainable components.
Accordingly, applicants have found that absorbent materials that are easy to prepare, recyclable and reusable, and also a simple method to impart antimicrobial properties to these materials and their applications ranging from healthcare applications, filters, water sterilization, to garment applications.
Brief Description of the Drawings
Embodiments of the invention are further described hereinafter with reference to the accompanying drawings, in which: Figure 1 is SEM images of the materials prepared according to Example 1 (top), Example 2 (middle) and Example 3 (bottom).
Figure 2 is a UV-VIS spectrum of the supernatant used to wash silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 7 at 70 °C for 120 minutes, of wash cycles 1(29-3 CurranAgW1), wash cycle 2(29-3 CurranAgW2) and wash cycle 4 (29-3 CurranAgW4).
Figure 3 is a cartoon explaining what materials were placed on an existing culture of bacteria on an agar plate or what materials were placed on an agar plate after which bacteria were allowed to grow(see Figures 4 and 5).
Figure 4 are images showing experimental results of GFP-expressing Escherichia coli EC5025 bacteria after 24 h contact with the composition according to the invention compared to controls.
All the plates are deposited in an identical pattern as depicted for 4A (as also explained by the cartoon of Figure 3) and are orientated in the same direction.
Figure 5 are images showing experimental results of GFP-expressing Pseudomonas syringae KP71 bacteria after 24 h contact with the composition according to the invention compared to controls. All the plates are deposited in an identical pattern as depicted for 5A (as also explained by the cartoon of Figure 3) and are orientated in the same direction.
Figure 6 is a photograph of a slurry of material prepared according to the method of Example 15, where GFP-SpyCatcher was attached to functionalised cellulose particulate material according to Example 12, varying the amount of GFP-SpyCatcher used. The mixture was washed several times in PBS to remove unbound components. From Figure 6 it can be observed that GFP-SpyCatcher is attached to the cellulose particulate material. The SpyCatcher motif contains a Histidine-tag for convenient analysis by for example standard Western Blotting techniques. From left to right we see the results of using a 25 Li.g/mL GFP (fluorescing), 50 Li.g/mL GFP (fluorescing more brightly), 100 pg/mL GFP (fluorescing more brightly still), 200 pg/mL GFP (fluorescing most brightly) and functionalised cellulose particulate material not contacted with GFP-SpyCatcher (not fluorescing).
Figure 7 is a photograph of a Western Blot, wherein Dispersin B (DSPB) or metal binding tagged Dispersin B (AgDSPB) are confirmed to be attached to cellulose particulate material or antimicrobial cellulose-containing microporous superabsorbent composition (-/-h silver metallisation) according to the invention and after three times washing in PBS. DSPB and AgDSPB contain a histidine tag, antibodies to which were used to detect the DSPB and AgDSPB on the Western Blot. DSPB can be bound to the cellulose particulate material at a ratio of about 1 Ltg / 10 mm2. Lanes labelled with 1 indicate ladder. Lanes 2 to 6 indicate cellulose material according to the invention, incubated for 16 h with PBS (lane 2), incubated for 4 h with DSPB (lane 3), incubated for 16 h with DSPB (lane 4), incubated for 4 h with AgDSPB (lane 5), incubated for 16 h with AgDSPB (lane 6).
Lanes 7 to 11 indicate silver metallised cellulose material according to the invention, incubated for 4 h with DSPB (lane 7), incubated for 16 h with DSPB (lane 8), incubated for 16 h with PBS (lane 9), incubated for 4 h with AgDSPB (lane 10), incubated for 16 h with AgDSPB (lane 11). Control lanes 12 to 17 indicate DSPB (lanes 12 to 14) or AgDSPB (lanes 15 to 17) at from left to right decreasing concentrations of DSPB or AgDSPB.
Figure 8 is a graph of the results of Example 14, wherein invertase was functionally assessed after attachment to the material according to the invention. See Example 14 for more details.
Summary of the Invention
In a first aspect, the present invention relates to a process for preparing an antimicrobial cellulose-containing microporous superabsorbent composition from an herbaceous plant material, the process comprising the steps of: (a) comminuting dry granulated herbaceous plant material to form microparticles having an average particle diameter of from 100 p.m to 800 pm; (b) optionally contacting the microparticles with an aqueous solution; preferably comprising an alkaline reagent, to wash out soluble components; removing the aqueous solution from the washed microparticles; and also optionally, drying the microparticles, and (c) optionally, forming a film and allowing the film to dry; and (d) at least once contacting the microparticles or the microparticle film with an antimicrobial agent precursor under conditions inducive of the formation, attachment or binding of an antimicrobial agent, and (e) isolating the antimicrobially modified microporous superabsorbent composition or the antimicrobially modified microporous film.
Applicants surprisingly was found that the absorbent materials as such has an inherent antiviral activity, at least initially before being wetted, and to delay growth of in particular enveloped viruses for a certain period of time. However, this activity can be exponentially improved by modification with an antimicrobial agent.
Detailed Description of the Invention
A number of antimicrobial materials based on leaching of low concentrations of silver ion from surfaces have also been reported, see for instance US 6,126,931 and US 6,030,632 describing biguanide polymers bonded a substrate, and subsequent bonding of silver salts to the immobilized biguanide polymer. The surface-bound biguanide polymer alone is shown as not inhibiting bacterial growth, but to adsorb the bacteria, thereby allowing the low-solubility silver salts to function as bactericide. A similar invention is reported in US 5,662,913, disclosing wound dressings comprising silver salts stabilized by polyether polymers, or US 5,856,248, using copper instead of silver salts. US 5,985,301 discloses cellulose fibres that contain silver as an antibacterial agent; herein, in short, cellulose is dissolved in a solvent, and then silver compounds are added. Fibres spun from the solutions were found to impart bactericidal properties. The publication however indicates that the thus obtained materials enhance antibacterial effects by promoting the discharge of silver ions from the silver-based antibacterial agent, i.e. allow leaching. However, neither the polyether nor the biguanide polymers are available directly from naturally occurring products, and are not easily digested or otherwise recyclable.
In order to enhance the function of cellulose-containing products, various peptides and proteins can also advantageously be attached thereto. For example, peptides or proteins bound to cellulose formed into a paper sheet are used in the industry for screening or diagnostic purposes by screening for peptide-protein interactions or enzymatic (coloured) reactions. In the medical and hygiene industries the disinfective properties of cellulose-containing materials such as wound-dressings, face masks and garments, can be enhanced by the attachment of antimicrobial peptides or proteins (AMP). These are just but a few examples of the myriad of uses of cellulose-peptide/protein compositions.
A common method of attaching proteins or enzymes to cellulose is the 1-Cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) method, which is an expensive and time-consuming method. Prior to the attachment of peptides or proteins the cellulose can be treated to enhance the attachment. TEMPO ((2,2,6,6-tetramethylpiperidin-1-yl)oxyl)-oxidized cellulose nanofibers have been used as a cellulose material upon which peptides or proteins are immobilized via electrostatic interactions or covalent immobilization (TEMPO-Oxidized Nanofibrillated Cellulose as a High Density Carrier for Bioactive Molecules -Weishaupt et al, 2015). AMPs have also been immobilized on TEMPO-oxidized cellulose nanofibers after for example functionalization of the fibers with alkyl ketene dimer (Immobilization of antimicrobial peptides onto cellulose nanopaper -Gonzalez et al, 2017). W02016156878 provides an alternative approach to linking peptides or proteins to cellulose fibers by using virus particles as a linking intermediary.
There remains a need in the industry for cellulose-containing material, to which peptides and proteins can be attached via simple and fast methods, while maintaining a strong and efficacious bond between the cellulose and the peptides or proteins. Specifically, there remains a need for improved antimicrobial material comprising cellulose and antimicrobial peptides or proteins.
The persistence and continued growth of microorganisms can cause several problems, especially when they adhere to each other and/or to living or non-living surfaces in large numbers. In industry, a concentrated population of microorganisms can disrupt normal processes by blocking conduits, pipelines and filters and cause contamination of products. In general use and in the healthcare industry, the microorganisms can become a source of infection and disease.
A compounding problem exists when the microorganisms produce a biofilm, which is a composition comprising one or more different species of microorganisms, such as for example bacteria, archaea, fungi, protozoa, algae and viruses, entrenched within an extracellular matrix comprising polymers, polysaccharides, proteins, nucleic acids and/or lipids. Biofilms form a defensive barrier against commonly used anti-microbial agents offering increased resistance against for example detergents and antibiotics. It is known that this increased resistance can promote recalcitrant infections or antibiotic resistance. Moreover, biofilms are difficult to remove.
In order to prevent or reduce the growth of microorganisms on surfaces and the formation of biofilms, several strategies have been developed. One of these is the use of antimicrobial peptides or proteins (AMP), that are known to be very effective in preventing or destroying biofilms and generally immune to development of bacterial resistance. AMPs are widely used in nature by various organisms as defense against pathogens. Natural occurring AMPs range in size from several to more than 100 amino acids. They vary in structure, but generally share an overall positive charge and a high proportion of hydrophobic residues. This structure allows AMPs to have a broad antipathogenic activity and to selectively associate with highly negatively charged microbial membranes and cause defects sufficient for cell death. AMPs have been used to control the formation of biofilms and to destroy existing biofilms, see for instance Yasir M, Willcox MDP, Dutta D. Action of Antimicrobial Peptides against Bacterial Biofilms. Materials (Basel). 2018 Dec 5;11(12):2468. It is also known that some AMPs may retain their activity upon immobilization on solid surfaces. In order to prevent the attachment and growth of microorganisms on cellulose containing material and potential formation of biofilms, it would be therefore be advantageous to have AMPs attached to the cellulose.
Various approaches for linking AMPs to cellulose are described in ACS Appl. Bio Mater.
2020) 3, 8, 4895-4901, but these require multiple chemical processing steps of the cellulose and/or the peptides to obtain modified cellulose and/or peptides suitable for covalent linking.
Green Fluorescent Protein (GFP) was engineered to be fused to a SpyCatcher motif, resulting in GFP-SpyCatcher and recombinantly produced in E.coli. The SpyCatcher motif is purported to readily form isopeptide bonds with its interacting SpyTag partner. This can be used to fuse proteins of interest, which are in turn fused to SpyTag, to GFP-SpyCatcher. When GFP-SpyCatcher is attached to the cellulose particulate material according to the invention this then can be used to attach SpyTag-fused proteins to the GFP-SpyCatcher and thus to the cellulose particulate material. Accordingly, this is a method to attach peptides or proteins to the cellulose particulate material that do not (easily) attach by themselves according to the method of the invention or that are only functional under non-carbonate conditions.
The inventors provide herein also an improved, simple and cost-effective method for the attachment of peptides or proteins to cellulosic absorbent particulate material resulting in an improved composition material comprising cellulose particulate material and peptides or proteins, wherein the peptides or proteins remain functional and strongly attached. 'Attachment' of peptides or proteins according to the invention herein is understood to mean the stable colocalization of peptides or proteins with cellulose particulate material after several washing steps with water at room temperature.
Moreover, the inventors provide herein an improved antimicrobial material to address the shortcomings of the prior art by providing a composition material, wherein cellulose particulate material is antimicrobially functionalized via a strong and efficacious attachment of a multitude of antimicrobial peptides or proteins, and optionally a small amount of metal material. The combined antimicrobial effect of the components was found to be more effective than any of the components by themselves, in particular with regard to the prevention of biofilm formation on or adherence of microorganisms to the cellulose. The composition material can be obtained by simple and cost-effective methods.
Adsorbents for Wound Dressings In connection with the care and treatment of wounds, the term "wound" is meant to include burns, pressure sores, punctures, ulcers and the like. For a long time, one critical aspect of wound care has been the consideration of the requirements of the epithelium, i. e., that area of new cell growth directly peripheral to the wound which is formed during the healing process, so that healing is facilitated.
Since it has been recognized that healing of the wound occurs in one sense as the epithelium migrates by growth from the periphery inward, care has been taken not to damage unnecessarily or to irritate this new area of growth or existing, compromised periwound tissue. With many dressings, problems can occur during dressing changes. This is particularly true where the dressing adheres to the epithelium or where granulation tissue and new cell growth become intertwined within the matrix of a dressing. In these instances, there is a risk that removal of the dressing will damage the sensitive tissue and new growth on the periphery of the wound thereby causing a regression in the progress of wound healing.
Still, another important consideration in wound care is the needs of the surrounding unwounded skin. The unwounded skin beyond the epithelium is usually in contact with some portion of the wound dressing system which maintains the dressing positioned on the wound. For example, the surrounding skin may be covered for extended periods with a wrap and/or adhesive to hold the dressing in place. Many such dressings can irritate this surrounding skin and compound problems to the patient. This is especially true in the area of leg ulcers wherein the surrounding skin can easily become sensitized by strong medicaments and is often plagued with flaking, scaling and eczema.
It is apparent that, considering the various types of wounds, numerous dressings that are available, and the various stages of healing, there is still a tremendous need for a dressing that functions better than the current dressings, especially with respect to preventing damage to surrounding skin, tissue and new cell growth. In particular, a wound dressing system which protects the epithelium and surrounding non-wounded skin, which wicks away moisture from the wound area, and which does not purposely adhere to the wound or the surrounding area would be a useful addition to the wound care art. A dressing for patients with fragile skin surrounding a wound would be especially beneficial.
An ideal adsorbent for wound dressing should not only absorb exudate but also possess antimicrobial or antibacterial properties. As used herein, "antibacterial" refers to as having an adverse effect on bacteria, particularly disease-causing bacteria. As used herein, the term "antiviral" refers to as having an adverse effect on virus or the spread of viral diseases.
Furthermore, "antimicrobial" is defined as having an adverse effect on a range of pathogenic microorganisms, including bacteria and at least some fungi and viruses. An antimicrobial adsorbent is generally preferred over an antibacterial adsorbent.
As used herein, the term "nanoparticle" refers to a particle of matter that is between 1-250 nm in diameter as determined by dynamic light scattering.
As used herein, the term "bound" refers to a material physiosorbed (physically absorbed) or chemisorbed (chemically bound) to another material.
As used herein, the term "metallised" refers to the materials wherein metal nanoparticles have been formed.
As used here, the term "attachment" is understood to mean the stable colocalization of peptides or proteins with cellulose particulate material after several washing steps with water at room temperature.
As used herein, "a," "an," "the," "at least one," and "one or more" are used interchangeably. Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range. The terms "comprises" and variations thereof do not have a limiting meaning where these terms appear in the description and claims. The words "preferred" and "preferably" , advantageous refer to embodiments of the invention that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
Plant Material: The starting material for the materials according to the present invention comprises herbaceous plant material. The term "herbaceous" as defined herein refers to plants which are annual, biennial or perennial vascular plants. In annual, biennial or perennial vascular plants, the stem matter dies after each season of growth when the plant becomes dormant, i.e. biennial or perennial plants, or dies, i.e. annual plants. Biennial or perennial plants survive unfavorable conditions underground and will regrow in more favorable conditions from such underground portions of the plant, typically stem, roots, or storage organs such as tubers. In contrast, the stems of woody species remain during any period of dormancy, and in a period of further growth will form growth rings which expand the girth of existing tissue. Herbaceous plants are characterized by parenchymal tissue having an abundance of primary cell walls within the tissue. One skilled in the art would also be aware that the mosses and macro algae also consist of an abundance of primary cell walls, and hence are included within the term "herbaceous plant material" as used herein. Herbaceous plant material is preferably used as a starting material within the present invention. Optionally, the starting material of the present invention substantially consists of herbaceous plant material. It can be advantageous for the starting material of the present invention to consist of herbaceous plant material, and thereby exclude wood or wood products. Depending upon the intended end use of the cellulose-containing material, however, it may not, however, be necessary to totally avoid inclusion of non-herbaceous plant material such as wood within the plant starting material.
In particular, the plant material used in the process of the present invention can conveniently include vegetables, for example root vegetables, and fruit. Non-limiting examples of suitable root vegetables include carrot, sugar beet, also commonly referenced as "beet", turnip, parsnip and swede. Exemplary fruit materials which can be used within the present invention includes apples, pears, citrus and grapes. Optionally, the plant material may be from tubers, for example potato; sweet potato, yam, rutabaya and yucca root can also be used, as well as micro and macro algae.
Generally, it is anticipated that the process of the invention will be operated using waste or coproducts from the plant material after a main product has been extracted, for example sugar beet pellets, vegetable peelings or citrus waste after juicing, jam-making or the like. However this is not strictly necessary, and the process could be operated using vegetable or fruit grown specifically for that purpose. It is also not necessary for the plant material to be used as a starting material in the process of the present invention to comprise material from only one specific plant source.
Optionally, a mixture of materials from different plant sources can be used. For example, the starting material can comprise a mixture of different root vegetables, a mixture of different fruits, a combination of fruit and vegetable(s), including a mixture of root vegetables together with a mixture of fruits.
Generally, the plant material to be used as a starting material for the present invention will not comprise a significant quantity of lignin. Optionally, the starting material for the present invention will comprise less than about 20 wt.% lignin, for example less than about 10 wt.% lignin, for example less than about 5 wt.% lignin, for example less than 2 wt.% lignin, for example less than about 1 wt.% lignin. A number of methods for the measurement of lignin content are known in the art and include methods such as the "Klason method", the acetyl bromide method and the thioglycolic acid method. Hatfield and Fukushima (Crop Sci. 45:832-839, 2005) discuss methods of lignin measurement.
The plant material preferably comprises chemically untreated raw plant material, i.e. uncooked. Alternatively, it may have been subjected to an extraction step to remove water soluble compounds.
A particularly preferred plant material comprises sugar beet (beta vulgaris) materials obtained after the sugar juice extraction step. Other suitable materials may be passed through a similar process, e.g. orange peels or apple residue obtained from pressing of juice. Ideally, in this process, the raw plant materials are washed to remove any non-plant material debris or contaminants and leaves. Then typically juice is obtained from those plant materials, by washing and cut up into chips having a thickness in the range of from 0.2 to 0.5 cm. In case of sugar beets, sugar is extracted from these chips typically by contacting the chips with hot extraction water, usually in a counter-current direction in an extraction tower. The crude extract is then usually filtered off, and further worked up. The remaining chips were found to form a particularly good starting material for the present process. In the production of sugar, sugar beets are harvested, washed and processed in sugar beet cutting machines to form chips. The beet chips are subsequently extracted with hot water, at a temperature ranging of from 65° C to 75° C, generally in a counter-current flow direction, and primarily using a diffusion process, and eventually a physical separation, such as pressing and/or centrifugation. This results in extracted sugar beet chips and sugar-containing raw sugar beet juice.
These extracted sugar beet chips primarily comprise of the cell wall and fibre constituents of the extracted sugar beet. In a subsequent processing stage, the beet chips are typically further dewatered by pressing them in so-called pulp presses, which results in pressed chips and released press water, optionally also using pressing aids. These dewatered and pressed chips are then typically subjected to a thermal removal of the residual water. Herein, the pressed chips are dried at an elevated temperature in rotating and heated drying drums, evaporating residual water and constituents volatile at the conditions. Conventional drying systems apply a so-called high-temperature drying, whereas alternative drying methods make use of indirect drying by means of superheated steam using a fluidized-bed method. Sugar-containing molasses are typically added at this stage if the pressed chips are to be employed as animal feed component. The pressed and dried chips are then usually pelletized, by simultaneously pressing the chips to obtain a compressed composition, and by passing the compressed composition through a granulator such as an extruder or hammer mill, wherein the composition is pelletized. The thus obtained pellets are usually added to animal feedstuff, typically those enriched with sugar-containing molasses.
The plant material may also be treated prior to, or after comminuting to a smaller particle size. Accordingly, the material may be subjected to a process involving contacting the plant material or obtained with a suitable reagent, such as an alkaline reagent, such caustic soda or lye, and/or water, or an aqueous solution of a peroxide, such as hydrogen peroxide, and/or an oxidative treatment, such as e.g. a hypochlorite. It is not essential for the reagent to be added simultaneously with the water. However, it is often convenient to add the water and reagent simultaneously. For example, it is possible to premix the reagent with the water and then to add the water-reagent mixture to the plant material, or microparticles. Alternatively, it is possible to add water to the particles of plant material to form an aqueous slurry, and then to add the reagent to the slurry. Advantageously, addition of the water and/or reagent is accompanied by stirring of the resultant mixture to facilitate formation of a homogenous composition. The volume of water to be added is not particularly critical, but may typically be from 2 litres to 30 litres water per kg plant material particles. This is in addition to any solution of reagent which may additionally be added. One of the benefits of the present invention is the relatively high percentage of solids which can be present within the mixture after the addition of water and reagent. In some embodiments, the mixture formed in step (a) can contain more than 2 wt.% solids. In some embodiments, the mixture formed in step (a) can contain at least 3 wt.% solids, for example at least 4 wt.% solids, at least 5 wt.% solids, at least 6 wt.% solids, at least 7 wt.%, at least 8 wt.% solids, at least 9 wt.% solids, or at least 10 wt.% solids.
This treatment step is intended to essentially to not break down the particles, but to remove components that may dissolve easily, and hence later may lead to leaching out of the antimicrobial agents. The process may then be followed by a filtration and washing step to remove unused reagent and soluble components, and drying step.
The cellulosic product, whether washed, treated and washed or directly obtained from a process to remove juices or other desired components is then subjected to a comminution step, e.g. by milling the materials, to obtain a microparticulate material.
The microparticulate material thus obtained was found to be able to super-adsorb fluids, e.g. water in an amount of from 3 to 6 times its dry weight. Also, it was found that the material is doing so very swiftly. Without wishing to be bound to any particular theory, this is believed due to the inherent capillary porosity of the material, which allows wicking of a fluid.
Surprisingly, it was found that the materials as such inherently have good antiviral activity against certain viruses, particularly enveloped viruses, such as COVID and influenza viruses. Enveloped viruses preferably have an envelope comprising a lipid bilayer.
This is in particular relevant since it has proven difficult to produce an effective disinfectant that does not readily wash out of the material, in particular when subjected to an industrial or household detergents and washing and drying processes. Hence "wash-out", or leaching usually occurs, which reduces effectiveness and may cause irritation, or infections. This is a general problem where absorptive packings are placed in contact with significant possibility for dangerous pathogen load, e.g. viral load, or bacterial growth.
In addition, due to the globalization of transport, the emergence of new diseases and pandemics, the uses for a technology that imparts a essentially non-leaching re-useable antimicrobial modification to a variety of materials is duly recognized. Specific areas of use in are described below herein.
And last but not least, sustainable materials would be desired which may simply be subjected to compost preparations, preferably after extraction of valuable antimicrobial components, metals and the like.
Production of the Superabsorbent Materials The absorbent particles can be formed using any suitable means. Preferably, water or other liquid is not added to the plant material prior to comminution to form the particles. Thus, the plant material is not in the form of a slurry or suspension during the comminution step. Thus the process can include a step of comminuting plant material in the absence of liquid to form particles of plant material. Optionally, the plant material contains less than 30 wt.% water prior to comminution, for example contains less than 20 wt.% water, for example contains less than 15 wt.% water. In some embodiments, the plant material can be dried (e.g. at ambient temperature or at higher temperatures) before being formed into particles. The comminuted material can be screened to select particles of the desired size.
The particles of plant material can be formed by grinding or milling. For example, the plant material can be processed in a mill or using a grinding apparatus such as a classifier mill to provide particles of the required diameter size.
Preferably, a combination of a mechanically acting mill, i.e. one where the plant materials is crushed and torn apart and thus comminuted between actors, and a subsequent particle sizing is employed, e.g. by gravity or density, or sieving. However, the apparatus used to produce the particles from the plant material is not particularly critical to the successful operation of the process.
Methods for comminuting are not limited in particular, and include, for example, methods by a ball mill, a rod mill, a hammer mill, an impeller mill, a high-speed mixer, attritor mills and/or a disk mill. Of these, preferred are attritor or cell mills, as described for instance in publication W02013/167851, or in US3131875, US3339896, US3084876, and US3670970. In an attritor mill, a high shear field for is attained causing attrition or size reduction of the solid particulate matter. A particularly useful cell mill, coupled with sieves, may be obtained from Atritor Limited, Coventry. Particle Size and Particle Size Distribution: The particles of plant material used within the process of the present invention have a mean average diameter of from 10 pm to 1000 pm, preferably of from 100 pm to 300 pm. The term "diameter" refers to the measurement across the particle from one side to the other side. One skilled in the art would recognise the particles would not be perfectly spherical, but may be near-spherical, ellipsoid, disc-shaped, or even of irregular shape. One skilled in the art would also be aware that a range of diameters would be present within the starting material. To obtain the benefits of the present invention, it is not necessary to meticulously exclude very small quantities of particles which fall outside the stated particle diameter size. However, inclusion of particles of different diameter sizes within the starting material can, in some circumstances, adversely affect the quality of the end product.
Optionally, at least 60% by volume of the particles have a diameter of from 10 pm to 1000 pm, for example at least 70% by volume of the particles have a diameter of from 10 p.m to 1000 pm, or at least 80% by volume of the particles have a diameter of from 10 pm to 1000 p.m, or at least 85% by volume of the particles have a diameter of from 10 pm to 1000 pm, or at least 90% by volume of the particles have a diameter of from 10 pm to 1000 p.m, or at least 95% by volume of the particles have a diameter of from 10 pm to 1000 pm, or even at least 98% by volume of the particles have a diameter of from 10 pm to 1000 Rm. Conveniently 99% by volume of the particles have a diameter of from 10 p.m to 1000 Rm. In some circumstances it may be advantageous to ensure that substantially all of the particles have a diameter of from 10 p.m to 1000 Rm.
Depending upon the source of the starting material and/or the intended end use of the cellulose-containing material, it can be advantageous to select particles having a mean average particle diameter size within a narrower range. For example, particles of plant material used within step (a) of the process of the present invention can have a mean average diameter of from 50 pm to 800 pm, or from 100 pm to 600 p.m. In some circumstances, at least 60% by volume of the particles have a diameter of from 50 pm to 800 pm, for example at least 70% by volume of the particles have a diameter of from 50 pm to 800 pm, or at least 80% by volume of the particles have a diameter of from 50 pm to 800 pm, or at least 85% by volume of the particles have a diameter of from 50 p.m to 800 p.m, or at least 90% by volume of the particles have a diameter of from 50 pm to 800 pm, or at least 95% by volume of the particles have a diameter of from 50 pm to 800 pm, or even at least 98% by volume of the particles have a diameter of from 50 pm to 800 pm. Conveniently, 99% by volume of the particles have a diameter of from 50 pm to 800 pm. In some circumstances it may be advantageous to ensure that substantially all of the particles have a diameter size of from 50 pm to 800 pm.
Alternatively, the particles of plant material used within step (a) of the process of the present invention can have a mean average diameter of from 75 pm to 400 pm. In some circumstances, at least 60% by volume of the particles have a diameter of from 100 pm to 300 pm, for example at least 70% by volume of the particles have a diameter of from 100 p.m to 300 pm, or at least 80% by volume of the particles have a diameter of from 100 pm to 300 pm, or at least 85% by volume of the particles have a diameter of from 100 pm to 300 pm, or at least 90% by volume of the particles have a diameter of from 200 pm to 400 pm, or at least 95% by volume of the particles have a diameter of from 200 p.m to 400 pm, or even at least 98% by volume of the particles have a diameter of from 200 pm to 400 pm. Conveniently 99% by volume of the particles have a diameter of from 200 pm to 400 pm. In some circumstances it may be advantageous to ensure that substantially all of the particles have a diameter of from 200 pm to 400 pm.
Particles of the required diameter and within the predetermined particle size distribution can be selected using known methods, including (but not limited to) sieving the particle mixture with one or more sieves of known sieve size.
For example, passing the material sample through a sieve having a mesh size of 500 pm will only allow particles having a particle diameter of 500 pm of less to pass through. The sieved material can then be sieved again using a sieve having a smaller mesh size, for example a mesh size of 300 pm. The particles retained on the smaller mesh (i.e. which do not pass through) will have a particle size distribution of 200 pm and range in size from 300 pm to 500 p.m. Of course, sieves of alternative sieve size and in different combinations can be used to obtain any required particles diameter size range and particle size distribution. Alternatively, a classifier mill or other suitable means can be used to select particles of the required particle size and size distribution.
Step (c) may comprises washing, or, if desired, neutralising the hydrated mixture to form a washed hydrated mixture.
As indicated above, step (c) can include one or more washing steps. Typically, washing requires the cellulose material to be separated from the liquid fraction, and then re-suspended (optionally with agitation or stirring) in clean liquid, such as water. The washing step essentially removes any excess reagent, and also any soluble by-products formed in step (a).
Also, if a treatment has been applied, the mixture may be washed, and/or neutralised, to a desired pH. Neutralising the mixture of step (b) after the end point pH has been reached can reduced or even eliminate the requirement for a washing step, thereby reducing the amount of water consumed during the manufacturing process, which is an important environment consideration. Neutralisation can be achieved by addition of an appropriate amount of an acid in an amount sufficient to change the pH of the mixture to a neutral pH. The acid can be added in any convenient form, but typically will be added as a powder or in the form of an aqueous solution. Alkalis such as sodium hydroxide, potassium hydroxide, calcium carbonate or the like can conveniently be used for the treatment. Optionally, once the hydrated mixture has been neutralized (and optionally mixed therewith), the cellulose-containing material can be separated from the liquid fraction by any suitable means.
Alternatively, the step of neutralisation can be performed after the cellulose-containing material has been separated from the liquid fraction. For example, the cellulose-containing material can be separated and then re-suspended before a suitable amount of acid is added. Alternatively, the separated cellulose-containing material can simply be suspended in an acidic solution. The step of separating the cellulose-containing material from the liquid fraction can be achieved using any suitable apparatus or process, including without limitation filtration (simple or vacuum filtration), centrifugation, membrane filtration etc. A woven filter can be used. Alternatively a mesh filter can be used. Optionally, where filtration is used during the washing step, the filter has a pore size of 200 pm or less, for example has a pore size of 100 pm to 200 pm. A smaller pore size can also be used.
Optionally, the washing step (c), and neutralising step if present, is conducted in a manner which is compatible with a continuous manufacturing process. For example a filter at an angle of approximately 45° to the horizontal may advantageously be used, with the material to be filtered being dropped onto the filter from above so that liquid drains through the filter whilst solids are retained on the upper surface of the filter. The angle of the filter cause these retained solids to slide gently down the filter's upper surface onto a belt, or into a hopper or other receptacle ready for further processing. Alternatively a belt filter press can be used.
Optional step (d): Once step (c) is complete (including any optional neutralising steps), the obtained material may be isolated, and water removed. The material may be dried to touch dryness; e.g. comprising a water content equivalent to exposure of dry material to average air humidity; or dried further and package under exclusion of air humidity. Methods for drying are well-know, and include drying cylinders, rotating drums, belts and the like, typically heated by superheated steam or hot air; and also may include reduced pressure (vacuum drying). Preferred is heat drying under reduced pressure. Drying may preferably be done by subjecting the materials to air flow at elevated temperatures in rotating and heated drying drums, evaporating residual water and constituents volatile at the conditions. Conventional drying systems apply a so-called high-temperature drying, whereas alternative drying methods make use of indirect drying by means of superheated steam using a fluidized-bed method.
Additionally, the materials, whether obtained in step (d) or (e), may be modified by adding functional materials, e.g. additional antimicrobial compounds; colouring or pigmentation, or any other useful modifications, such as shaping or compressing into certain shapes or products, optionally with packaging.
Step e: After step (c) or optionally after step (d), the obtained the microparticles are contacted with an antimicrobial agent precursor under conditions inducive of the formation, attachment or binding of an antimicrobial agent.
In one embodiment, the cellulose microparticles are functionalised with antimicrobial nanoparticles so as to form an antimicrobial agent.
The antimicrobial nanoparticles may be selected from any nanoparticular material wherein 95 wt.% of the particles have a mean average diameter of 1-250 nm. The antimicrobial nanoparticles are bound to the surface of the fibres of the microparticles. It has been surprisingly found that nanoparticles bound to the cellulose active material do not de-attach from the cellulose active material under conditions emulating washing, even at 70 C. Without wishing to be bound by theory, it is believed that the nanoparticles physical incorporation within the fibrous network of the cellulose active material particles provides additional protection from physical ablation of the nanoparticles during washing.
Preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs), gold nanoparticles [AuNPs] or copper nanoparticles (CuNPs). More preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs), or copper nanoparticles (CuNPs). Most preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs).
Optionally, the antimicrobial nanoparticles may be pre-formed and contacted with the microparticles to bind the antimicrobial nanoparticles to the microparticles so as to form an antimicrobial agent. The preformed antimicrobial nanoparticles therefore as an antimicrobial agent precursor and by binding to the fibres of the microparticles form an antimicrobial agent. This can be achieved by immersing the microparticles into a colloidal suspension bearing the preformed nanoparticles, followed by isolation of the nanoparticle-binding microparticles by filtration and washing of said isolated nanoparticle-binding microparticles. Preferably, the nanoparticles are provided as an aqueous solution.
Preferably, the pre-formed antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs), gold nanoparticles [AuNPs] or copper nanoparticles (CuNPs). More preferably, the pre-formed antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs) or copper nanoparticles (CuNPs). Most preferably, the pre-formed antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs).
Alternatively, the antimicrobial nanoparticles may be formed in-situ. Here the nanoparticle pre-cursors act as an antimicrobial agent precursor and by forming nanoparticles at the surface of the fibres of the microparticles form an antimicrobial agent. Suitable nanoparticle pre-cursors may be selected from known nanoparticle precursors, such as copper salts, silver salts or gold salts.
Particularly favoured nanoparticle precursors are copper sulfate (CuSO4), copper acetate (Cu(OAc)2), silver nitrate (AgNO3) and the chlorides of gold, including gold (Ill) chloride (Au2CI6), chloroauric acid (HAuClit) and gold (i) chloride (AuCI), preferably copper sulfate (CuSO4), silver nitrate (AgNO3) and chloroauric acid (HAuC14), most preferably silver nitrate (AgNO3).
The nanoparticle precursors may be provided as a solution, preferably as an aqueous solution. Preferably, the nanoparticle precursors are provided as a 0.01-50 micromolar (mMol dm-3) solution on the basis of the metal containing compound, more preferably 0.1-20 micromolar, most preferably 1-10 micromolar.
Surprisingly, the inventors found that no reducing agent was required to form nanoparticles in situ when contacted with the microparticles. Optionally, additional reducing agents may be used to expedite nanoparticle formation.
The solution of nanoparticle precursors may be contacted with the microparticles by immersion of the microparticles in a solution of the nanoparticle precursors. Alternatively, a solution of nanoparticle precursors may be spray coated onto the microparticles.
Preferably, nanoparticle formation is performed under illumination with light, preferably light of a wavelength of 300-500 nm, more preferably 350-450 nm, yet more preferably 380-420 nm, most preferably 390-400 nm.
Preferably, nanoparticle formation is conducted at from 0 to 150 °C, more preferably from 10 to 110 °C, yet more preferably from 15 to 60 T and most preferably from 20 to 30 C. Preferably, nanoparticle formation is conducted as part of a continuous process, wherein the microparticles prepared by steps described above are contacted with at least one. For example, the microparticles prepared by steps described above may be spray coated with a solution of nanoparticle precursors. Suitable nanoparticle pre-cursors may be selected from known nanoparticle precursors, such as copper salts, silver salts or gold salts. Particularly favoured nanoparticle precursors are copper sulfate (CuSO4), copper acetate (Cu(OAc)2), silver nitrate (AgNO3) and the chlorides of gold, including gold (111) chloride (Au2CI6), chloroauric acid (HAuC14) and gold (i) chloride (AuCI), preferably copper sulfate (CuSO4), silver nitrate (AgNO3) and chloroauric acid (HAuC14), most preferably silver nitrate (AgNO3). The particularly favoured nanoparticles may be provided as an aqueous solution.
More preferably) nanoparticle formation is conducted as part of a continuous process, wherein the microparticles prepared by steps described above are contacted with at least one nanoparticle precursor followed by irradiation with light of a wavelength of 300-500 nm. Suitable nanoparticle pre-cursors may be selected from known nanoparticle precursors, such as copper salts, silver salts or gold salts. Particularly favoured nanoparticle precursors are copper sulfate (CuSO4), copper acetate (Cu(OAc)2), silver nitrate (AgNO3) and the chlorides of gold, including gold (111) chloride (Au2CI6), chloroauric acid (HAuC14) and gold (i) chloride (AuCI), preferably copper sulfate (Cu504), silver nitrate (AgNO3) and chloroauric acid (HAuCk), most preferably silver nitrate (AgNO3). The particularly favoured nanoparticles may be provided as an aqueous solution. nanoparticle formation is performed under illumination with light, preferably light of a wavelength of 300-500 nm, more preferably 350-450 nm, yet more preferably 380-420 nm, most preferably 390-400 nm.
Most preferably, nanoparticle formation is conducted as part of a continuous process, wherein the microparticles prepared by steps described above are contacted with an aqueous solution of silver nitrate (AgNO3), followed by irradiation with of a wavelength of 300-500 nm.
In an alternative embodiment, the cellulose active material particles are functionalised with antimicrobial peptide and/or proteins.
Preferably, the peptides and/or proteins are antimicrobial. More preferably the antimicrobial peptides or proteins comprise peptides or proteins having an amino acid sequence selected from the group consisting of AU1, AU2, AU3, 1037, LF1-11, KR12, lactoferrampin, FK-16 and Dispersin B (SEQ ID NOs 1 to 9). AU1 has an amino acid sequence of SEKLFFGASL (SEQ ID NO 1).
AU2 has an amino acid sequence of SEKLWWGASL (SEQ ID NO 2). AU3 has an amino acid sequence of GASLWWSEKL (SEQ ID NO 3). Lactoferrampin has an amino acid sequence of WNLLRQAQEKFGKDKSP (SEQ ID NO 7). FK-16 has an amino acid sequence of FKRIVQRIKDFLRNLV (SEQ ID NO 8) or FKRIVCIRIKDFLRNLV-amide. 1037 has an amino acid sequence of KRFRIRVRV (SEQ ID NO 4) or KRFRIRVRV-amine. The amino acid sequences and their SEQ ID NOs of the preferred antimicrobial peptides and proteins according to the invention are set out in Table A below.
Table A. Amino acid sequences and SEQ ID NOs of the preferred antimicrobial peptides and proteins according to the invention SEQ ID NO Name Sequence 1 AU1 SEKLFFGASL 2 AU2 SEKLWWGASL 3 AU3 GASLWWSEKL 4 1037 KRFRIRVRV LF1-11 GRRRSVQWCAV 6 KR12 KRIVQRIKDFLR 7 Lactoferrampin WNLLRQAQEKFGKDKSP 8 FK-16 FKRIVORIKDFLRNLV 9 Dispersin B NCCVKGNSIYPQKTSTKQTGLM LDIARHFYSPEVIKSFIDTISLSGG NFLHLHFSDHENYAIESHLLNQRAENAVQGKDGIYINPYTGKPFLS YRQLDDIKAYAKAKGIELIPELDSPNHMTAIFKLVQKDRGVKYLQG LKSRQVDDEIDITNADSITFMQSLMSEVIDIFGDTSQHFHIGGDEF GYSVESNHEFITYAN KLSYFLEKKGLKTRM WNDGLIKNTFEQIN PN lEITYWSYDGDTQDKNEAAERRDMRVSLPELLAKGFTVLNYNSYYL YIVPKASPTESQDAAFAAKDVIKNWDLGVWDGRNTKNRVC/NTH EIAGAALSIWGEDAKALKDETIQKNTKSLLEAVIHKTNGDE Dispersin B is a family 2013-hexosaminidase originating from the oral pathogen Aggregatibacter actinomycetemcomitans, also known as Actinobacillus actinomycetemcomitans. Preferably, the peptides and/or proteins have a metal binding domain, more preferably a copper, silver or gold binding domain, most preferably a silver binding domain.
In an alternative embodiment, the cellulose active material particles are functionalised with both (i) antimicrobial nanoparticles and (H) antimicrobial peptides and/or proteins.
Preferably, the peptides and/or proteins have a metal binding domain, more preferably a copper, silver or gold binding domain, most preferably a silver binding domain.
The antimicrobial nanoparticles may be selected from any nanoparticular material wherein wt.% of the particles have a mean average diameter of 1-250 nm. The antimicrobial nanoparticles are bound to the surface of the fibres of the microparticles. It has been surprisingly found that nanoparticles bound to the cellulose active material do not de-attach from the cellulose active material under conditions emulating washing, even at 70 °C. Without wishing to be bound by theory, it is believed that the nanoparticles physical incorporation within the fibrous network of the cellulose active material particles provides additional protection from physical ablation of the nanoparticles during washing.
Preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs), gold nanoparticles [AuNPs] or copper nanoparticles (CuNPs). More preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs) or copper nanoparticles (CuNPs). Most preferably, the antimicrobial nanoparticles are selected from silver nanoparticles (AgNPs).
Optionally, the antimicrobial nanoparticles may be pre-formed and contacted with the microparticles to bind the antimicrobial nanoparticles to the microparticles so as to form an antimicrobial agent. The preformed antimicrobial nanoparticles therefore as an antimicrobial agent precursor and by binding to the fibres of the microparticles form an antimicrobial agent. This can be achieved by immersing the microparticles into a colloidal suspension bearing the preformed nanoparticles, followed by isolation of the nanoparticle-binding microparticles by filtration and washing of said isolated nanoparticle-binding microparticles. Preferably, the nanoparticles are provided as an aqueous solution.
Preferably, the antimicrobial nanoparticles may be formed in-situ. Here the nanoparticle pre-cursors act as an antimicrobial agent precursor and by forming nanoparticles at the surface of the fibres of the microparticles form an antimicrobial agent. Suitable nanoparticle pre-cursors may be selected from known nanoparticle precursors, such as copper salts, silver salts or gold salts. Particularly favoured nanoparticle precursors are copper sulfate (CuSO4), copper acetate (Cu(OAc)2), silver nitrate (AgNO3) and the chlorides of gold, including gold (III) chloride (Au2CI6), chloroauric acid (HAuC14) and gold (i) chloride (AuCI), preferably copper sulfate (Cu504), silver nitrate (AgNO3) and chloroauric acid (HAuC14), most preferably silver nitrate (AgNO3).
Forming antimicrobial nanoparticles in-situ confers the advantage of particularly great resistance to the thereby formed nanoparticles "washing-out" or leaching from the material. Without being bound by theory, it is believed that formation of the nanoparticles in-situ may result in the nanoparticles forming within the network of cellulosic fibres of the microparticles, thereby physically trapping the fully formed nanoparticles within the network.
The nanoparticle precursors may be provided as a solution, preferably as an aqueous solution. Preferably, the nanoparticle precursors are provided as a 0.01-50 micromolar (mMol dm-3) solution on the basis of the metal containing compound, more preferably 0.1-20 micromolar, most preferably 1-10 micromolar.
Surprisingly, the inventors found that no reducing agent was required to form nanoparticles in situ when contacted with the microparticles. Optionally, additional reducing agents may be used to expedite nanoparticle formation.
The solution of nanoparticle precursors may be contacted with the microparticles by immersion of the microparticles in a solution of the nanoparticle precursors. Alternatively, a solution of nanoparticle precursors may be spray coated onto the microparticles.
Preferably, nanoparticle formation is performed under illumination with light, preferably light of a wavelength of 300-500 nm, more preferably 350-450 nm, yet more preferably 380-420 nm, most preferably 390-400 nm.
Preferably, nanoparticle formation is conducted at from 0 to 150 °C, more preferably from 10 to 110 °C, yet more preferably from 15 to 60 T and most preferably from 20 to 30 C. In a particularly favoured combination, the peptides and/or proteins have a copper, silver or gold binding domain and the nanoparticles are formed in-situ from corresponding a copper, silver or gold containing nanoparticle precursor, of which the combination of peptides and/or proteins having a silver binding domain and a silver containing nanoparticle precursor is most favoured. Without being bound by theory, it is believed that the metal binding domain of the peptide and/or protein and the nanoparticle act to enhance "attachment" of the peptides and/or proteins to the cellulose-containing microporous superabsorbent composition. The cellulose-containing microporous superabsorbent composition comprising both (i) antibiofilm/antibacterial peptides/proteins and (ii) antimicrobial nanoparticles surprisingly demonstrated synergistic antibacterial properties.
Step f: After step (e) the antimicrobially modified microporous superabsorbent composition is isolated. This can be achieved by isolation of the antimicrobially modified microporous superabsorbent composition by filtration, followed by washing.
Optional step g: a film may be formed from the antimicrobially modified microporous superabsorbent composition.
In preferable embodiment, the process for preparing an antimicrobial and cellulose-containing microporous superabsorbent composition comprises: (1) performing the process for preparing a preparing an antimicrobial nanoparticle-containing cellulose-containing microporous superabsorbent composition according to any of the suitable embodiments describes above; (2) performing the process for preparing a preparing an antimicrobial protein-containing and/or peptide-containing cellulose-containing microporous superabsorbent composition according to any of the suitable embodiments describes above; and (3) blending the antimicrobial nanoparticle-containing cellulose-containing microporous superabsorbent composition and the antimicrobial protein-containing and/or peptide-containing cellulose-containing microporous superabsorbent composition.
This embodiment advantageously allows for a simplified preparation of a superabsorbent compositions comprising both anti-microbial nanoparticles and antimicrobial proteins and/or peptides.
Uses of the Cellulose-Containing Material: The present materials are superabsorbent with an advantageous liquid storage capacity combined with a liquid wicking efficacy. Hence, these superabsorbent materials are economically viable for use in absorbent articles and are fully biodegradable, so that disposal of the absorbent articles used is environmentally friendly.
The term "absorbent article" generally refers to a device that can absorb and contain fluids. As used herein, absorbent articles include baby sanitary products such as diapers, baby wipes, bowel training pants and other disposable garments; Feminine hygiene products such as sanitary napkins, wipes, sanitary pads, pantiliners, panty shields, tampons and tampon applicators; Adult sanitary products such as wipes, pads, incontinence products, urine shields, furniture pads, bed pads and head bands; Public, industrial and household products such as wipes, covers, filters, paper towels, bath tissues and facial tissues; Nonwovens, such as nonwoven rolls; Home comfort products, such as pillows, pads, cushions and masks; And professional and consumer hygiene products, including but not limited to surgical drapes, hospital gowns, wipes, wraps, covers, bands, filters and disposable garments.
Preferred or alternative features of each aspect or embodiment of the invention apply mutatis mutandis to each aspect or embodiment of the invention (unless the context demands otherwise).
The term "comprising" as used herein means consisting of, consisting essentially of, or including and each use of the word "comprising" or "comprises" can be independently revised by replacement with the term "includes", "consists essentially of or "consists of" . Any modifications and/or variations to described embodiments that would be apparent to one of skill in art are hereby encompassed. Whilst the invention has been described herein with reference to certain specific embodiments and examples, it should be understood that the invention is not intended to be unduly limited to these specific embodiments or examples.
The absorbent materials according to the invention, optionally modified, advantageously may be used in wound dressing, sanitary pad, a tampon, an intrinsically antimicrobial absorbent dressing, a diaper, toilet paper, a sponge, a sanitary wipe, food preparation surfaces, gowns, gloves, surgical scrubs, sutures, needles, sterile packings, floor mats, lamp handle covers, burn dressings, gauze rolls, blood transfer tubing or storage container, mattresses, applicators, exam table coves, head covers, cast liners, splint, paddings, lab coats, air filters for autos, planes or HVAC systems, military protective garments, face masks, devices for protection against biohazards and biological warfare agents, food packaging material, and other materials that would profit from biodegradable and antimicrobial properties.
In connection with the care and treatment of wounds, the term "wound" is meant to include burns, pressure sores, punctures, ulcers and the like. For a long time, one critical aspect of wound care has been the consideration of the requirements of the epithelium, i. e., that area of new cell growth directly peripheral to the wound which is formed during the healing process, so that healing is facilitated.
The above summary of the present invention is not intended to describe each disclosed embodiment or every implementation of the present invention. The description that follows more particularly exemplifies illustrative embodiments.
The present invention is now further described with reference to the following non-limiting examples.
Example 1-Preparation of cellulose-containing microporous superabsorbent composition Sugar-beet pellets were subjected to a milling step in an attritor mill, selecting a composition comprising at a weight average particles size of from 100 jim to 300 p.m, and subsequently subjected to a water washing and drying step, to obtain a cellulose-containing microporous superabsorbent composition.
Example 2-Preparation of antimicrobial cellulose-containing microporous superabsorbent composition comprising silver nanoparticles g of the cellulose-containing microporous superabsorbent composition of Example 1 was treated with 700 mL of a 5 mM aqueous solution of AgNO3 at 25°C for two hours. The suspension was filtered, the retained solids then dried under a flow of air at 25 °C for 12 hours. The dried material was then suspended in 700 mL of water at 25°C for two hours. The suspension was filtered, the retained solids then dried under a flow of air at 25 C. The dried material was then washed with water three times. Each water wash consisted of suspending the solid material in 1400 mL of water for 10 minutes at 25 °C, followed by isolation of the solid by filtration. The isolated, thrice washed solid material was then dried under a flow of air at 25 °C for 12 hours. ICP-MS analysis established 681(±11) mg/kg of silver was incorporated into the material, which means approximately 12% of the silver present in the aqueous silver salt was incorporated into the material on an elemental basis.
Example 3 -Preparation of antimicrobial cellulose-containing microporous superabsorbent composition comprising gold nanoparticles The cellulose-containing microporous superabsorbent composition of Example 170 g was treated with 700 m of a 5 mM aqueous solution of HAuC14.3H20 at 25°C for two hours. The suspension was filtered, the retained solids then dried under a flow of air at 25 C. The dried material was then suspended in 700 mL of water at 25 °C for two hours. The suspension was filtered, the retained solids then dried under a flow of air at 25 C. The dried material was then washed with water three times. Each water wash consisted of suspending the solid material in 1400 mL of water for 10 minutes at 25 °C, followed by isolation of the solid by filtration. The isolated, thrice washed solid material was then dried under a flow of air at 25 C. ICP-MS analysis established 7500(±399) mg/kg of silver was incorporated into the material, which means approximately 80% of the fold present in the aqueous sold salt was incorporated into the material on an elemental basis.
Table 1 -Fluid absorbance of antimicrobial cellulose-containing microporous superabsorbent compositions Material Example 1 Example 3 [AgNP] Example 4 [AuNP] Water absorbance 4.957 6.145 4.967 [g(water)/g(material)] Example 4 -Elemental Analysis (ICP-MS) of Materials according to the invention Materials prepared according to Examples 2 and 3 were digested in aqua regia (21% HCl/9% HNO3) and the resultant aqueous solution analysed in triplicate by Inductively Coupled Plasma Mass Spectrometry (ICP-MS) using a Perkin Elmer AVIO 500 in a laboratory accredited under ISO 17025. Samples were diluted if required to bring results within the calibration range. Standard and QC solutions were made from stocks traceable to NIS and the method utilises multi-point calibration with the following standards:10, 6,4, 2 and 1 ppm metal. The results are reproduced in Table 2.
Table 2
Material Example 2 Example 3 Silver (mg/kg) 681(±11) 0 Gold (mg/kg) 0 7500(±399) % incorporation of available metal into material 12 80 Example 5 -Antiviral activity of antimicrobial cellulose-containing microporous superabsorbent compositions according to the invention The antiviral activity of antimicrobial cellulose-containing microporous superabsorbent compositions according to the invention were evaluated by the protocol of ISO 18184:2019.
Formulations comprising cellulose active material were tested for their viricidal activity against Influenza A virus or Human coronavirus NL63 at a contact time of 2 h relative to a reference control, following 15018184:2019. The formulations tested were (1) cellulose-containing microporous superabsorbent composition of Example 1, (2) silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 3 and (4) gold metallised (AuNP) cellulose-containing microporous superabsorbent composition of Example 3. The results are shown in Tables 3 and 4.
Table 3: Effect against Influenza A. A value of 2.0> Mv n.0 indicates good antiviral effect. A value of 3.0> Mv 2.0 indicates very good antiviral effect. A value of Mv 3.0 indicates excellent antiviral effect. *Affected cell susceptibility not valid for 15018184. ;cellulose active material form vs Influenza A [H1N1] % Mv Cytotoxic Affects cell ISO reduction (antiviral activity) sensitivity compliant Cellulose-containing microporous superabsorbent composition of Example 1 99.9 3.17 N Y N* Silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 2 99.9 3.93 N N V Gold metallised (AuNP) cellulose-containing microporous superabsorbent composition of Example 3 99.9 3.93 N N V Table 4: Effect against Influenza A. A value of 2.0> Mv indicates good antiviral effect. A value of 3.0> Mv 2.0 indicates very good antiviral effect. A value of Mv 3.0 indicates excellent antiviral effect.
cellulose active material form vs Human Coronavirus [NL63] % Mv Cyto-toxic Affects cell ISO reducti on (antiviral activity) sensitivity compliant Cellulose-containing microporous superabsorbent composition of Example 1 99.9 3.53 N N Y Silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 2 99.9 3.22 N N Y Gold metallised (AuNP) cellulose-containing microporous superabsorbent composition of Example 3 99.9 3.25 N N Y As can be seen from Tables all the cellulose-containing microporous superabsorbent compositions exhibited good to excellent viricidal activity with a 99.9% reduction in viral titre (both influenza A and human coronavirus) at a contact time of 2 h relative to a reference control, following 15018184:2019 accredited procedures. Under these conditions all were ISO compliant except cellulose-containing microporous superabsorbent composition of Example 1 since although they had potent antiviral activity, they were found to slightly influence growth of the type of cells used in the influenza assay.
Example 6 -Antibacterial activity of antimicrobial cellulose-containing microporous superabsorbent compositions according to the invention The antibacterial activity of antimicrobial cellulose-containing microporous superabsorbent compositions according to the invention were evaluated. Formulations comprising cellulose active material were tested for their antibacterial control activity against Escherichio coil, Pseudomonos syringae and Saccharomyces cerevisiae cultures. The formulations tested were (1) cellulose-containing microporous superabsorbent composition of Example 1, (2) silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 2 and (3) gold metallised (AuNP) cellulose-containing microporous superabsorbent composition of Example 3. The protocol used contacted 100 pl aqueous cell suspensions with 100 mg of antimicrobial cellulose-containing microporous superabsorbent composition for 2 hours at ambient conditions, 1 mL of culture media added, vortexed and plated, and triplicate counts of microbial colonies were obtained. By comparing numbers of colonies obtained from the cell suspensions exposed to the materials with colony numbers obtained from suspensions that had no contact with the materials we were able to calculate the capacity of the materials to inhibit microbial growth (% control). % control data are reproduced in Table 5.
Table 5: Control Data for microbial growth (% control).
% control E.coli % control Ps. Syr KP71 % control Socc. cer Cellulose-containing microporous superabsorbent composition of Example 1 97 100 67 Silver metallised (AgNP) cellulose-containing microporous superabsorbent composition of Example 2 100 100 100 Gold metallised (AuNP) cellulose-containing microporous superabsorbent composition of Example 3 100 100 90 Example 7 -Preparation of antimicrobial cellulose-containing microporous superabsorbent composition comprising silver nanoparticles utilising UV-radiation The cellulose-containing microporous superabsorbent composition of Example 10.5 g was evenly distributed over an area to achieve a depth of 1 mm of material within a weighing boat. 5 mL of a 5 mM aqueous solution of AgNO3 was added to the weighing boat to fully immerse the cellulose-containing microporous superabsorbent composition material. The mixture was mechanically agitated for 5 seconds, then irradiated with UV radiation (395 nm, 9 bulb torch 10 cm from weighing boat) for 4 minutes. The suspension was filtered, the retained solids then dried under a flow of air at 25°C. The dried material was then washed with water three times. Each water wash consisted of suspending the solid material in 10 mL of water for 10 minutes at 25 °C, followed by isolation of the solid by filtration. The isolated, thrice washed solid material was then dried under a flow of air at 25°C for 12 hours.
Example 8-Leaching test of antimicrobial cellulose-containing microporous superabsorbent composition comprising silver nanoparticles To establish that the antimicrobial cellulose-containing microporous superabsorbent composition do not exhibit loss of adhered silver nanoparticles on washing, the following test was 20 conducted.
g of antimicrobial cellulose-containing microporous superabsorbent composition material was suspended in 4000 mL of water and 0.5 mL of non-biological detergent. The suspension was stirred for 2 hours at 70 °C, filtered through filter paper with a pore size of 5-13 pm, washed 3 times with 500 mL of water, dried at 60 C. This cycle was repeated 5 times. The wash supernatant analysed by UV-Vis spectroscopy An antimicrobial cellulose-containing microporous superabsorbent composition comprising silver nanoparticles prepared according to Example 8 was tested. The material did not exhibit any loss of colour or intensity of colour, which is indicative that the silver nanoparticles were retained within the material. As can be seen in Figure 2, the absence of a peak in the 350-400 nm region in the supernatant confirms no significant loss of silver nanoparticles from the functionalised cellulose active material particles on washing.
Example 9 -Preparation of simulated face mask material comprising cotton and silver metallised (AgNP) cellulose-containing microporous superabsorbent composition A simulated face mask material comprising cotton and silver metallised (AgNP) cellulose-containing microporous super absorbent composition was made according to the following process: A BCI cotton base-sheet (106 ± 3% g/m2) was provided. A Muratex spreading and pressing machine was used to scatter coat the base-sheet with 200 mg/m' of a mixture. The mixture was solely composed of silver metallised (AgNP) cellulose-containing microporous super absorbent composition prepared according to Example 2 [54 wt.%] and adhesive powder particles (Ecofix Hot-Melt Powder) [46 wt.%]. The scatter coating was realized with a hollow needle that rapidly moved across the cotton base-sheet to provide an even distribution of the powder mixture over the base-sheet. A BCI cotton top-sheet (106 ± 3% g/m2) was then laid on to the base-sheet to enclose the powder between the sheets. The sheets were then passed though hot rollers twice (9 tonnes of pressure equivalent), where the hot rollers applied heat and pressure to melt the adhesive and adhere the base-sheet to the top-sheet around the silver metallised (AgNP) cellulose-containing microporous super absorbent composition particles.
Example 10-Preparation of TEMPO cellulose-containing microporous superabsorbent composition The cellulose-containing microporous superabsorbent composition prepared according to Example 1 was oxidised by [method].
Example 11-Analysis of viricidal activity of simulated face mask material comprising cotton and silver metallised (AgNP) cellulose-containing microporous superabsorbent composition The viricidal activity of a simulated face mask material comprising a cotton and silver metallised (AgNP) cellulose microporous superabsorbent composition (prepared according to Example 10) was analysed by adding 100 pl phage Phi6 (DSMZ 21518) suspension (diluted to -1e7 cfu/ml) in phage buffer (7 g1-1 Na2HPO4, 3 gl KH2PO4, g1-1 NaCI, 1 mM Mg504-7(H20), 1 mM CaCl2) to 1 cm2 of the material for 2 hours at ambient conditions in a 2 ml microtube. Subsequently 1 ml of phage buffer was added, vortexed for 15 seconds and centrifuged for 3 minutes at 1000g. The supernatant was removed and serially diluted in phage buffer. 100 pl aliquots were placed in 5 ml polypropylene tubes (VWR 211-0049) in triplicate. To each of these, 10 p.I of 24 hr old Pseudomonas host cells (DSMZ 21482), which were grown statically at 28 Tin TSB broth (Sigma 22092) supplemented with filter sterilised MgSO4 (to 5 mM) was added and then incubated for a maximum of 20 minutes. Subsequently, 3-4 ml of 47 °C molten TSB 0.5% agar supplemented with sterile Mg504 to 5 mM was added to each tube. Each tube was then poured on to the surface of petri plates containing 16 mls of solid 1.5% agar TSB plates supplemented with Mg504 to 5mM, before leaving to set for 20 minutes. Plates were then inverted and incubated at 25 °C for approximately 16 hrs or until visible plaques were observed. Triplicate plates were counted (where the dilution plated yielded between 30 and 300 visible plaques). Triplicate experiments were performed. The material was demonstrated to completely kill phage Phi6.
Example 12-Functionalisation of TEMPO cellulose particulate material with proteins A 1% (w/v)gel of TEMPO oxidised cellulose particulate material (prepared according to Example 1, then oxidised with a TEMPO solution) was washed three times, wherein a wash consisted of adding water to the cellulose particulate material slurry to its original volume, vortexing the mixture to resuspend the mixture, centrifuging the mixture at 4200 g for 5 minutes and decanting the supernatant. The cellulose particulate material was washed three additional times with a carbonate buffer (0.1M NaHCO3 pH 8.3) in the same fashion as above. The washed cellulose particulate material was resuspended in carbonate buffer to obtain a 1.2% stock of functionalised cellulose particulate material.
Proteins and/or enzymes were added to the 1.2% stock of functionalised cellulose particulate material resulting in a mixture comprising 1% (w/v) cellulose particulate material. The mixture was incubated from several hours to up to 60 hours and yielded a stable integration or attachment of the proteins or enzymes to the cellulose particulate material.
The following proteins were added as follows: Calf intestinal phosphatase (CIP) at a stock concentration of 3000 U/mg (New England Biolabs, M02905) was added at a concentration of 10 to 200 pg per ml of cellulose particulate material slurry (1% (w/v)). The mixture was incubated for 2 hours at room temperature (about 25 °C) and subsequently stored for future use in a 0.1M pH 8.3 carbonate buffer or phosphate buffered saline (PBS).
Invertase from bakers' yeast at a stock concentration of 300 U/mg (Sigma, 14504) was added at a concentration of 100 pg per ml of cellulose particulate material slurry (1% (w/v)). The mixture was incubated for about 16 hours and subsequently stored for future use in a 0.1M pH 4.5 acetate buffer.
GFP-SpyCatcher was added at a concentration of 25 pig to 2 mg per ml of cellulose particulate material slurry (1% (w/v)). The mixture was incubated for 16 hours or 60 hours and subsequently stored for future use in a 0.1M pH 8.3 carbonate buffer or phosphate buffered saline (PBS).
Dispersin B (DSPB) or Dispersin B containing a metal binding domain (AgDSPB) was added to cellulose particulate material slurry (1% (w/v)) that was not washed or contacted with carbonate buffer, and incubated for several hours.
Example 13-Functional attachment of CIP CIP was attached to functionalised cellulose particulate material according to Example 12 at a concentration of 0, 10, 20 or 40 pg/ml. The mixture was washed and centrifuged twice, after which the supernatants and composition material were assessed for functional attachment of CIP via a BCIP/NBT colorimetric assay. The colorimetric assay is a standard alkaline phosphatase activity assay wherein the substrates 5-bromo-4-chloro-3-indolylphosphate (BCIP) and nitro blue tetrazolium (NBT) are used to determine the activity of enzymes such as CIP via a colorimetric readout. It can be seen from Figure X that, although some of the CIP has not been attached as is evident from the supernatant colour change, CIP is attached to the cellulose particulate material.
Example 14 -Functional attachment of invertase Invertase was attached to functionalised cellulose particulate material according to Example 12. The mixture was then washed three times with water according to Example 12 at a centrifugation of 4122 g and resuspended in water to restore volume equal to the initial volume of TEMPO oxidised cellulose particulate material (1% w/v). The mixture was washed a further three times as with water above, but instead with a 0.1 M pH 4.5 acetate buffer to obtain a 1% (w/v) slurry.
To the slurries, different amounts of sucrose was added (100-0.1 mg/ml final volume in reaction volume of 1 ml) and the conversion of sucrose into glucose and fructose by invertase was measured at OD 410 nm according to the manufacturer's protocols, with samples taken at t = 0 minutes and t = 20 minutes. After the first reaction cycle (Cycle 1) the suspension was centrifuged, the supernatant decanted, and resuspended with more sucrose; equivalent to what was initially added. Samples were taken again at t = 0 minutes and t = 20 minutes (Cycle 2). In Figure 8 it can be seen that sucrose is converted into glucose and fructose thereby confirming the attachment of functional invertase to the cellulose particulate material.
Example 15-Functional attachment of GFP-SpyCatcher GFP-SpyCatcher was attached to functionalised cellulose particulate material according to Example 12. The mixture was washed several times in PBS to remove unbound components. From Figure 6 it can be observed that GFP-SpyCatcher is attached to the cellulose particulate material. The SpyCatcher motif contains a Histidine-tag for convenient analysis by for example standard Western Blotting techniques.
Example 16-Functional attachment of DSPB and AgDSPB DSPB or AgDSPB were attached to functionalised cellulose particulate material according to Example 12. The mixture was washed three times in PBS. From Figure 7 it can be observed that DSPB and AgDSPB can attach robustly to non-and silver-metallised cellulose particulate material. It was found that DSPB can bind at about 1 p,g/mm2 cellulose particulate material.
Example 17-continuous for preparing an antimicrobial cellulose-containing microporous superabsorbent composition comprising silver nano-particles (AgNP) The cellulose-containing microporous superabsorbent composition of Example 1 was deposited onto a moving conveyor belt to form a loose bed of 2-5 mm depth. The loose bed on the conveyor belt was run under a spraying unit, which sprayed the loose bed cellulose-containing microporous superabsorbent composition with 2 weight equivalents of a 5 mM aqueous solution of AgNO3 at 25 °C. The cellulose-containing microporous superabsorbent composition rapidly absorbed the 5 mM aqueous solution of AgNO3 to afford a loose, dampened bed of bed cellulose-containing microporous composition which has absorbed 2 weight equivalents of a 5 mM aqueous solution of AgNO3. This loose, dampened bed on the conveyor belt was run under a UV-light source and irradiated with UV light for 30 seconds. The resultant UV-light-irradiated loose bed of silver treated cellulose-containing microporous composition was then dried. The resultant material was analysed and found to comprise silver nanoparticles.
Example [DDD]-analysis of antibacterial behaviour of cellulose-containing microporous superabsorbent composition comprising [metal I nanoparticles with reductive virus structures. 8 mm diameter nanocellulose disks were punched from dried thin films of C3PN nanocellulose material prepared from 2% slurry stocks mixed with equal volume of distilled water or 25 mM silver nitrate solution. 5 ml of slurry/water/silver solution mix were pooled on plastic to an area of 4.5 cm diameter and left to dry for 16 hours at 25 °C, followed by thrice rinsing in distilled water then allowed to dry. 20 pl of Dispersin B in phosphate buffered saline (PBS) at 0.3 mg/ml or PBS only was applied to the disks, incubated for 16 hours in a damp chamber and then rinsed 3 x in 5 ml PBS.
An agar plate (Figures 3-5 [200]) was coated with bacteria which express green fluorescent protein. The plate was allowed to develop a lawn of bacteria which express green fluorescent protein (24 hours). The following were deposited onto the lawn: (1) a disk of silver metallised (AgNP) cellulose-containing microporous superabsorbent composition was treated with 20 jiL of water, which was placed onto the bacterial lawn (Figures 3-5 [100]); (2) a disk of silver metallised (AgNP) cellulose-containing microporous superabsorbent composition was treated with 20 jiL of phosphate-buffered saline, which was placed onto the bacterial lawn (Figures 3-5 [101]); (3) a disk of silver metallised (AgNP) cellulose-containing microporous superabsorbent composition was treated with 20 p.L of Dispersin B (non-silver binding) solution, which was placed onto the bacterial lawn (Figures 3-5 [102]); (4) a disk of silver metallised (AgNP) cellulose-containing microporous superabsorbent composition was treated with 20 p.L of Dispersin B (silver binding) solution, which was placed onto the bacterial lawn (Figures 3-5 [103]); (5) a disk of cellulose-containing microporous superabsorbent composition was treated with 20 )11_ of water, which was placed onto the bacterial lawn (Figures 3-5 [104]); (6) a disk of cellulose-containing microporous superabsorbent composition was treated with 20 pi of phosphate-buffered saline, which was placed onto the bacterial lawn (Figures 3-5 [105]); (7) a disk of cellulose-containing microporous superabsorbent composition was treated with 20 IL of Dispersin B (non-silver binding) solution, which was placed onto the bacterial lawn (Figures 3-5 [106]); (8) a disk of cellulose-containing microporous superabsorbent composition was treated with 20 lit of Dispersin B (silver binding) solution, which was placed onto the bacterial lawn (Figures 3-5 [107]); (9) 20 pi of water was directly placed onto the bacterial lawn (Figures 3-5 [108]); (10)20 pi of phosphate-buffered saline was directly placed onto the bacterial lawn (Figures 3-5 [109]); (11)20 pi of Dispersin B (non-silver binding) solution was directly placed onto the bacterial lawn (Figures 3-5 [110]); (12)20 pi of Dispersin B (silver binding) solution was directly placed onto the bacterial lawn (Figures 3-5 [111]); and (13)20 pi of bleach was directly placed onto the bacterial lawn (Figures 3-5 [112]); Alternatively the disks were applied to agar plates and the plates spread with bacterial culture (500 pl of OD 600 nm 0.2) and again left for 24 hours at 25°C for Ps. syringae KP71 and 37°C for E. coli EC5025. After 24 hours contact, the plates were imaged under white light, ultra-violet (UV) light with an orange filter, under UV with the disks of material removed, the disks themselves viewed under UV.
GFP expressing Ps. syringae KP71 and E. coli EC5025 were used as the bacterial test materials. Deposited materials 1-8 were shown to possess significant antibacterial activity. The results are shown in Figures 3-5.
Figure 3 shows the locations on the plate of each of the 13 deposited materials, which is maintained in the experimental results of Figures 4 and 5. Figure 3 can be used as a general reference for the locations of the deposited materials in Figures 4 and 5. For clarity, reference numbers [100] -[112] and [200] are only indicated on Figure 4A and 5A, but can be understood to be also present in the other images of Figures 4 and 5 on the same general positions.
Figures 4A, 4E, 5A and 5E are white light images taken from treated agar plates. Figures 4B, 4C, 4D, 4F, 4G, 4H, 5B, 5C, 5D, 5F, 5G and 5H are UV light orange filtered images taken from treated agar plates. Increased pixel intensity (i.e. brighter image) in the UV light images indicates an increased level of GFP, which correlates with a higher number of bacteria. Figure 4 shows results from the experiments using GFP expressing E. coli EC5025, while figure 5 shows results from the experiments using GFP expressing Ps. syringae KP71. Figures 4A-D and SA-D show the experiments as detailed above where the bacteria were allowed to develop a lawn for 24 h after which the materials and disks were deposited. Figures 4E-H and 5E-H show the experiments as detailed above where the materials and disks were deposited prior to applying the bacteria. Figures 4B, 4F, 5B and 5F show the plates with the disks. Figures 4C, 4G, Sc and 5G show the plates with the disks removed. Figures 4D, 4H, 5D and 5H show the filter disks after removal from the plates.
As can be clearly seen from the Figures, the silver metallised (AgNP) cellulose-containing microporous superabsorbent composition displayed strong antibacterial properties, whereas the bleach, Dispersin B and unfunctionalized cellulose-containing microporous superabsorbent composition displayed modest antibacterial properties. This is evident when comparing the lower pixel intensity (i.e. lower number of bacteria) of [100], [101], [102] and [103] of Figures 4B, 4C, 4D, 4F, 4G, 4H, 5B, 5C, 5D, 5F, 5G and 5H to the higher pixel intensity of the other treated areas. The silver metallised (AgNP) cellulose-containing microporous superabsorbent composition reduced both the number of bacteria on the plates (Figures 4C, 4G, 5C and 5G) and had a reduced number of bacteria on the disks (Figures 4D, 4H, 5D and 5H) when compared to controls and the non-silver metallised cellulose-containing microporous superabsorbent composition.
Moreover, there was a strong, unexpected synergistic antibacterial function of the combination of silver metallised (AgNP) cellulose-containing microporous superabsorbent composition treated with 20 IA of Dispersin B (both silver binding and non-silver binding) solution (see [102] and [103] of Figures 4D, 4H, 5D and 5H), which was strongest for the silver binding Dispersin B solution.
Claims (26)
- Claims 1. A process for preparing an antimicrobial cellulose-containing microporous superabsorbent composition from an herbaceous plant material, the process comprising the steps of: (a) comminuting dry granulated herbaceous plant material to form microparticles having an average particle diameter of from 100 pm to 800 pm; (b) optionally contacting the microparticles with an aqueous solution; preferably comprising an alkaline reagent, to wash out soluble components; removing the aqueous solution from the washed microparticles; and also optionally, drying the microparticles, and (c) optionally, forming a film and allowing the film to dry; and (d) at least once contacting the microparticles or the microparticle film with an antimicrobial agent precursor under conditions inducive of the formation, attachment or binding of an antimicrobial agent, and (e) isolating the antimicrobially modified microporous superabsorbent composition or the antimicrobially modified microporous film.
- 2. The process according to claim 1, wherein step (d) includes a. contacting at least a portion of the microparticles, or a film formed from the microparticles according to (a) to (c), with a solution comprising a sufficient quantity of a antimicrobial agent precursor; b. maintaining the contact of the microparticles or film with the solution under acceptable conditions for a sufficient period of time to complete the reaction, wherein the reaction comprises forming antimicrobial agent on or in the substrate, attaching the antimicrobial agent to or binding the antimicrobial agent to; c. optionally subjecting the mixture to irradiation, preferably by UV light; d. rinsing the obtained substrate to remove non-reacted antimicrobial agent precursor and/or reaction products; and, e. drying the substrate to a desired low moisture content.
- 3. The process according to claim 1 or claim 2, wherein the antimicrobial agent precursor is selected from antimicrobial peptides and/or proteins, preferably wherein the antimicrobial peptides or proteins comprise peptides or proteins having an amino acid sequence selected from the group consisting of AU1, AU2, AU3, 1037, LF1-II, KR12, lactoferrampin, FK-16 and Dispersin B (SEQ ID NOs 1 to 9) , most preferably Dispersin B (SEQ ID NO 9).
- 4. The process according to claim 3, further comprising including a step (dl), comprising the steps of: i. contacting the cellulose particulate material with (2,2,6,6-tetramethylpiperidin-1-yl)oxyl (TEMPO); ii. optionally contacting the TEMPO-treated cellulose particulate material with an alkaline solution to provide a solution of functionalized cellulose; optionally drying the solution of functionalized cellulose; and iv. contacting the cellulose or the functionalized cellulose with the antimicrobial peptides and/or proteins to obtain the antimicrobial peptides and/or protein modified cellulose particulate material.
- 5. The process according to claim 4 further comprising 1.1. washing the cellulose particulate material obtained in i. with water and/or an alkaline solution.
- 6. The method according to claim 4 or claim 5, wherein the cellulose particulate material is provided in an aqueous solution at a concentration of from 0.1 to 10% (w/v).
- 7. The method according to any one of claims 4 to 6, wherein the alkaline solution is a buffered solution, preferably comprising carbonate and/or an alkali metal, more preferably NaHCO3, preferably wherein the solution has a pH of from 7 to 13, more preferably of from 7.5 to 9.0, even more preferably of from 8.0 to 8.5.
- 8. The process according to any one of claims 1 to 7, wherein an antimicrobial agent precursor is selected from suitable metal nanoparticle pre-cursors, preferably selected from copper salts, silver salts or gold salts, more preferably selected from copper sulfate (Cu504), copper acetate (Cu(OAc)2), silver nitrate (AgNO3) and the chlorides of gold, even more preferably selected from copper sulfate (CuSO4), silver nitrate (AgNO3) and chloroauric acid (HAuC14) and most preferably selected from silver nitrate (AgNO3).
- 9. The process according to any one of claims 4 to 7, comprising following a TEMPO-treated cellulose particulate material with a metallizing treatment, to obtain a multiply modified composition comprising antimicrobial peptide and metal modification.
- 10. The process according to claim 9, comprising contacting the composition or the peptides or proteins with a solution or suspension comprising a suitable metal nanoparticle pre-cursor, preferably wherein the solution or suspension is alkaline, preferably the alkaline solution or suspension is buffered, preferably comprising carbonate and/or an alkali metal, more preferably NaHCO3, and preferably having a pH of from 7 to 13, more preferably of from 7.5 to 9.0, even more preferably of from 8.0 to 8.5.
- 11. The process according to claim 9 or claim 10, comprising retaining the TEMPO-treated cellulose particulate material during contacting or washing in a container comprising openings of a size and dimension that prevents a substantial portion of the cellulose particulate material from passing through.
- 12. The process according to any one of claims lo 11, wherein an antimicrobial agent precursor comprises one or more antimicrobial peptides or proteins, preferably wherein the antimicrobial peptides or proteins comprise peptides or proteins having an amino acid sequence selected from the group consisting of AU1, AU2, AU3, 1037, LF1-II, KR12, lactoferrampin, FK-16 and Dispersin B (SEQ ID NOs 1 to 9), most preferably Dispersin B (SEQ ID NO 9).
- 13. The process according to any one of claims 1 to 12, wherein the rinsing is performed with an aqueous solution, and additionally comprising the step of dewatering the substrate after the rinsing step.
- 14. A cellulosic superabsorbent material comprising a fluid-adsorbent volume area obtained according to the process of any one of the preceding claims, comprising one or more of a biologically and/or chemically active antimicrobial agent(s), and configured to render the material antimicrobial when exposed to a microbial agent.
- 15. The material according to claim 14, for use in contacting fluids, prefearbly aqueous fluids, including menses, bodily fluids, skin, cosmetic compositions, or wound exudates.
- 16. The material according to claim 14, wherein the material is shaped into, or comprised in, a wound dressing, a sanitary pad, a tampon, an absorbent dressing, a diaper, a sponge, a sanitary wipe, an isolation and surgical gown, a glove, a surgical scrub, sutures, sterile packaging, a floor mat, a burn dressing, a mattress cover, bedding, an air filter for vehicles, planes, buildings or generally for HVAC systems, a water filter, military protective garment, a face mask, a device for protection against biohazards and biological warfare agents, lumber, paper, cardboard, meat or fish packaging material, paionts and coatings, apparel for food handling, and other surfaces or materials required to exhibit a non-leaching antimicrobial property and to release over time portions of biologically or chemically active compounds.
- 17. The material of claim 16, comprising all or part of a wound dressing, sanitary pad, a tampon, an intrinsically antimicrobial absorbent dressing, a diaper, toilet paper, a sponge, a sanitary wipe, food preparation surfaces, gowns, gloves, surgical scrubs, sutures, needles, sterile packings, floor mats, lamp handle covers, burn dressings, gauze rolls, blood transfer tubing or storage container, mattress cover, bedding, sheet, towel, underwear, socks, cotton swabs, applicators, exam table covers, head covers, cast liners, splint, paddings, lab coats, air filters for vehicles, planes or HVAC systems, water filters, military protective garments, face masks, devices for protection against biohazards and biological warfare agents, lumber, meat packaging material, paper currency, powders, and other surfaces required to exhibit an essentially non-leaching antimicrobial or enhanced microbial pathogen binding properties, and to release over time portions of the biologically or chemically active compound.
- 18. An inherently antimicrobial composition obtainable by the process according to any one of claims 1 to 13, comprising: a. an herbaceous cellulose-containing substrate; b. an antimicrobial agent adhered to the substrate, wherein the antimicrobial agent substrate, or surface area exhibits antimicrobial activity due to the presence of the antimicrobial agent.
- 19. The composition of claim 18, wherein the material comprises all or part of a wound dressing, sanitary pad, a tampon, an intrinsically antimicrobial absorbent dressing, a diaper, toilet paper, a sponge, a sanitary wipe, food preparation surfaces, gowns, gloves, surgical scrubs, sutures, needles, sterile packings, floor mats, lamp handle covers, burn dressings, gauze rolls, blood transfer tubing or storage container, mattress cover, bedding, sheet, towel, underwear, socks, cotton swabs, applicators, exam table coves, head covers, cast liners, splint, paddings, lab coats, air filters for vehicles such as automobiles, trains, boats or planes, air filters for architectural HVAC systems, water filters, military protective garments, face masks, devices for protection against biohazards and biological warfare agents, lumber, meat packaging material, paper currency, powders, water filters, and other surfaces required to exhibit a non-leaching antimicrobial or enhanced dye binding properties, and to release over time portions of the biologically or chemically active compound.
- 20. An antimicrobially modified composition according to claim 18, for the retention and/or destruction of microbes or viruses contacting the composition.
- 21. The composition according to claim 20, comprising a plurality of biologically and/or chemically active compounds selected from the group consisting of: antibiotics, analgesics, antiinflammatories, strong oxidizing agents, matrix metalloproteinase inhibitors, proteins, peptides, and fungicidal compounds.
- 22. The composition according to claim 21, wherein the cellulose particulate material further comprises metal and/or metal oxide material attached to the cellulose, preferably wherein the metal and/or metal oxides comprise copper, silver or gold, more preferably silver.
- 23. The composition according to claims 21 or 22, wherein the peptides or proteins are antimicrobial, preferably wherein the antimicrobial peptides or proteins comprise peptides or proteins having an amino acid sequence selected from the group consisting of AU1, AU2, AU3, 1037, LF1-1I, KR12, lactoferrampin, FK-16 and Dispersin B (SEQ ID NOs 1 to 9), most preferably Dispersin B (SEQ ID NO 9).
- 24. The composition according to any of claims 20 to 23, wherein the peptides or proteins comprise metal binding and/or metal reducing peptides, preferably further comprising metal and/or metal oxide material attached to the peptides or proteins.
- 25. The composition according to claim 21, wherein the peptides or proteins are antibacterial, antifungal, antiparasitic or antiviral, preferably antibacterial.
- 26. A method of treating or covering a wound, comprising contacting the wound with a substrate comprising the antimicrobially modified absorbent materials according to any one of claims 21 to 25.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2110423.7A GB2609039A (en) | 2021-07-20 | 2021-07-20 | Cellulosic microporous superabsorbent materials with tunable morphology |
PCT/EP2022/070401 WO2023001911A1 (en) | 2021-07-20 | 2022-07-20 | Biodegradable and reusable cellulosic microporous superabsorbent materials |
US18/580,652 US20240277888A1 (en) | 2021-07-20 | 2022-07-20 | Biodegradable and reusable cellulosic microporous superabsorbent materials |
EP22738700.8A EP4373272A1 (en) | 2021-07-20 | 2022-07-20 | Biodegradable and reusable cellulosic microporous superabsorbent materials |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2110423.7A GB2609039A (en) | 2021-07-20 | 2021-07-20 | Cellulosic microporous superabsorbent materials with tunable morphology |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202110423D0 GB202110423D0 (en) | 2021-09-01 |
GB2609039A true GB2609039A (en) | 2023-01-25 |
Family
ID=77443385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2110423.7A Withdrawn GB2609039A (en) | 2021-07-20 | 2021-07-20 | Cellulosic microporous superabsorbent materials with tunable morphology |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2609039A (en) |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3084876A (en) | 1959-02-24 | 1963-04-09 | Podmore Henry Leveson | Vibratory grinding |
US3131875A (en) | 1960-09-05 | 1964-05-05 | Szegvari Andrew | Method of and apparatus for grinding a solid in a liquid |
US3339896A (en) | 1966-06-03 | 1967-09-05 | Southwestern Eng Co | Stirring device |
US3670970A (en) | 1970-10-19 | 1972-06-20 | Andrew Szegvari | Method and apparatus for comminuting and reacting solids |
US5662913A (en) | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
US5856248A (en) | 1995-04-28 | 1999-01-05 | Weinberg; Amotz | Microbistatic and deodorizing cellulose fibers |
US5985301A (en) | 1997-09-30 | 1999-11-16 | Kenji Nakamura | Antibacterial cellulose fiber and production process thereof |
US6030632A (en) | 1993-12-20 | 2000-02-29 | Biopolymerix And Surfacine Development Company | Non-leaching antimicrobial films |
US6126931A (en) | 1993-12-20 | 2000-10-03 | Surfacine Development Company, Llc | Contact-killing antimicrobial devices |
EP2283130A1 (en) * | 2008-04-03 | 2011-02-16 | Kane Biotech Inc. | DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
WO2013167851A1 (en) | 2012-05-10 | 2013-11-14 | Belmonte Investments Limited | Attritor mill and process for using it |
WO2016156878A1 (en) | 2015-04-02 | 2016-10-06 | James Hutton Institute | Nanocomposite material |
-
2021
- 2021-07-20 GB GB2110423.7A patent/GB2609039A/en not_active Withdrawn
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3084876A (en) | 1959-02-24 | 1963-04-09 | Podmore Henry Leveson | Vibratory grinding |
US3131875A (en) | 1960-09-05 | 1964-05-05 | Szegvari Andrew | Method of and apparatus for grinding a solid in a liquid |
US3339896A (en) | 1966-06-03 | 1967-09-05 | Southwestern Eng Co | Stirring device |
US3670970A (en) | 1970-10-19 | 1972-06-20 | Andrew Szegvari | Method and apparatus for comminuting and reacting solids |
US5662913A (en) | 1991-04-10 | 1997-09-02 | Capelli; Christopher C. | Antimicrobial compositions useful for medical applications |
US6030632A (en) | 1993-12-20 | 2000-02-29 | Biopolymerix And Surfacine Development Company | Non-leaching antimicrobial films |
US6126931A (en) | 1993-12-20 | 2000-10-03 | Surfacine Development Company, Llc | Contact-killing antimicrobial devices |
US5856248A (en) | 1995-04-28 | 1999-01-05 | Weinberg; Amotz | Microbistatic and deodorizing cellulose fibers |
US5985301A (en) | 1997-09-30 | 1999-11-16 | Kenji Nakamura | Antibacterial cellulose fiber and production process thereof |
EP2283130A1 (en) * | 2008-04-03 | 2011-02-16 | Kane Biotech Inc. | DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
WO2013167851A1 (en) | 2012-05-10 | 2013-11-14 | Belmonte Investments Limited | Attritor mill and process for using it |
WO2016156878A1 (en) | 2015-04-02 | 2016-10-06 | James Hutton Institute | Nanocomposite material |
Non-Patent Citations (7)
Title |
---|
ACS APPL. BIO MATER., vol. 3, no. 8, 2020, pages 4895 - 4901 |
GONZÁLEZ ISRAEL ET AL: "Immobilization of antimicrobial peptides onto cellulose nanopaper", INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, vol. 105, 19 July 2017 (2017-07-19), pages 741 - 748, XP085237590, ISSN: 0141-8130, DOI: 10.1016/J.IJBIOMAC.2017.07.094 * |
HATFIELDFUKUSHIMA, CROP SCI, vol. 45, 2005, pages 832 - 839 |
RESHMY R ET AL: "Nanocellulose-based products for sustainable applications-recent trends and possibilities", REVIEWS IN ENVIRONMENTAL SCIENCE AND BIO-TECHNOLOGY, KLUWER, DORDRECHT, NL, vol. 19, no. 4, 3 October 2020 (2020-10-03), pages 779 - 806, XP037292421, ISSN: 1569-1705, [retrieved on 20201003], DOI: 10.1007/S11157-020-09551-Z * |
SINGLA RUBBEL ET AL: "Cytocompatible Anti-microbial Dressings of Syzygium cumini Cellulose Nanocrystals Decorated with Silver Nanoparticles Accelerate Acute and Diabetic Wound Healing", SCIENTIFIC REPORTS, vol. 7, no. 1, 1 December 2017 (2017-12-01), XP055905327, Retrieved from the Internet <URL:https://www.nature.com/articles/s41598-017-08897-9.pdf> DOI: 10.1038/s41598-017-08897-9 * |
SPERANDEO PAOLA ET AL: "Covalent Grafting of Antimicrobial Peptides onto Microcrystalline Cellulose", ACS APPLIED BIO MATERIALS, vol. 3, no. 8, 17 August 2020 (2020-08-17), US, pages 4895 - 4901, XP055905298, ISSN: 2576-6422, Retrieved from the Internet <URL:https://pubs.acs.org/doi/pdf/10.1021/acsabm.0c00412> DOI: 10.1021/acsabm.0c00412 * |
YASIR MWILLCOX MDPDUTTA D: "Action of Antimicrobial Peptides against Bacterial Biofilms", MATERIALS (BASEL, vol. 11, no. 12, 5 December 2018 (2018-12-05), pages 2468 |
Also Published As
Publication number | Publication date |
---|---|
GB202110423D0 (en) | 2021-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2747792B1 (en) | Wound dressing having a content of copper or copper ions | |
US7709694B2 (en) | Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces | |
KR101417557B1 (en) | Low ph, optimal orp, and odor-reducing fibers, a process for making the fibers, and articles made therefrom | |
EP2398508B1 (en) | Superabsorbent materials comprising peroxide | |
JPH05123358A (en) | Foul smell suppressing device | |
US20050033251A1 (en) | Controlled release of biologically active substances from select substrates | |
JPS60210256A (en) | Bacteria adsorbing composition and its production | |
CN107456321B (en) | A kind of nanometer silver antimicrobial sanitary napkin and its production method | |
US9414601B2 (en) | Material having antimicrobial activity when wet | |
US20190000676A1 (en) | Absorbent sheet | |
WO2019093700A1 (en) | Biodegradable sanitary pad and absorption pad for human body | |
KR20180066453A (en) | Hemostatic material comprising calcium carboxymethyl cellulose powder and water-soluble chitosan compound powder and process for preparing the same | |
US20240277888A1 (en) | Biodegradable and reusable cellulosic microporous superabsorbent materials | |
Goldade et al. | Antimicrobial fibers for textile clothing and medicine: current state | |
GB2609039A (en) | Cellulosic microporous superabsorbent materials with tunable morphology | |
KR20160103061A (en) | Odor control in personal care products | |
RU2398599C1 (en) | Copper-bearing cellulose textile material | |
EP1594555B1 (en) | Disposable feminine hygiene products | |
WO2012092812A1 (en) | Anti-bacterial, moisture absorptive and calcium ion donating wound dressing | |
GB2609040A (en) | Biodegradable and reusable cellulosic microporous superabsorbent materials | |
WO2023001909A1 (en) | Water absorbing and antimicrobial fabric composition | |
KR102301719B1 (en) | Diaper for adult | |
KR20190017585A (en) | functional hygienic goods and their preparation method | |
US20230372894A1 (en) | Disposable absorbent article with odor reducing agents | |
JPH07258972A (en) | Composite raw material comprising chitosan and protein material |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |